###begin article-title 0
###xml 94 99 <span type="species:ncbi:9606">human</span>
CpG methylation plays a vital role in determining tissue- and cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 binding
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 515 521 515 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 555 561 555 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 770 776 770 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 815 821 815 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 834 842 834 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 938 944 938 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1132 1139 1132 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1159 1165 1159 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1320 1326 1320 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 199 204 <span type="species:ncbi:9606">human</span>
Cell-death-inducing DFF45-like effector A (CIDE-A) belongs to a family of proapoptotic proteins, the expression of which is highly restricted in human tissues and cells. Here, the core region of the human CIDE-A promoter was characterized. Surprisingly, two Sp1/Sp3-binding sites, rather than tissue-specific transcription factors, were found to be required for the promoter activity. Although the ubiquitously expressed Sp1 and Sp3 were crucial, they alone could not adequately regulate the specific expression of CIDE-A. We found that the expression of CIDE-A was further regulated by CpG methylation of the promoter region. By performing bisulfite sequencing, we observed dense CpG methylation of the promoter region in tissues and cells with low or no expression of CIDE-A but not in tissues with high level of CIDE-A expression. In vitro methylation of this region showed significantly reduced transcriptional activity. Treatment of CIDE-A-negative cells with 5-aza-2'-deoxycytidine demethylated the CpG sites; this opened the closed chromatin conformation and markedly enhanced the binding affinity of Sp1/Sp3 to the promoter in vivo, thereby restoring CIDE-A expression. These data indicated that CpG methylation plays a crucial role in establishing and maintaining tissue- and cell-specific transcription of the CIDE-A gene through the regulation of Sp1/Sp3 binding.
###end p 2
###begin title 3
GenBank Accession Number
###end title 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 471 474 471 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2 B3 B4">2&#8211;4</xref>
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 885 891 885 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1063 1064 1063 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1142 1148 1142 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1252 1253 1252 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1492 1493 1484 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1502 1508 1494 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1663 1666 1655 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7 B8 B9">7&#8211;9</xref>
###xml 410 416 <span type="species:ncbi:9606">humans</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 1076 1081 <span type="species:ncbi:9606">women</span>
###xml 1300 1305 <span type="species:ncbi:9606">human</span>
Apoptosis, a morphologically distinct form of programmed cell death, is an evolutionary highly conserved phenomenon that plays an important role in the regulation of cellular activities in eukaryotes (1). Recently, a novel family of cell-death-inducing DFF45 (DNA fragmentation factor-45)-like effector (CIDE) proteins has been identified. The CIDE family includes three members (CIDE-A, CIDE-B and CIDE-C) in humans, and their mice homologues have also been identified (2-4). CIDE-A was initially identified by virtue of its sequence similarity to the N-terminal region of the apoptotic DNA fragmentation factors DFF40/CAD and DFF45/ICAD. The overexpression of CIDE-A in various cell lines induces caspase-independent cell death associated with the fragmentation of DNA (3). In addition to cell-death induction, recent studies have indicated a correlation between CIDE-A and obesity. CIDE-A-null mice are resistant to diet-induced obesity and diabetes and display higher metabolic rate and lipolysis in the brown adipose tissue than their wild-type littermates (5). In obese women undergoing weight reduction through a low-calorie diet, the CIDE-A gene is the highest upregulated gene in the subcutaneous adipose tissue among 8000 investigated genes (6). Furthermore, CIDE-A is considered to play a human-specific role in lipolysis regulation and metabolic complications of obesity, which is at least partly mediated by cross-talk between CIDE-A and tumor necrosis factor-alpha (TNF-alpha) (7). Thus, CIDE-A is also considered as a strong candidate gene for obesity and could serve as a novel target for therapeutic intervention of obesity and Type II diabetes (7-9).
###end p 5
###begin p 6
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDEs</italic>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 291 297 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 459 461 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 470 474 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE</italic>
###xml 598 604 586 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-B</italic>
###xml 670 671 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 708 714 696 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-C</italic>
###xml 783 784 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 808 814 796 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-B</italic>
###xml 883 889 871 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-B</italic>
###xml 971 973 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1022 1027 1010 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FSP27</italic>
###xml 1163 1164 1151 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1198 1202 1186 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE</italic>
###xml 1386 1392 1374 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 592 597 <span type="species:ncbi:9606">human</span>
###xml 702 707 <span type="species:ncbi:9606">human</span>
###xml 802 807 <span type="species:ncbi:9606">human</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
###xml 1380 1385 <span type="species:ncbi:9606">human</span>
According to the previous reports, the expression of CIDEs is strongly tissue and cell specific. In addition to high levels of expression in the adipose tissue, CIDE-A transcripts of various lengths are present in different human tissues such as the heart, muscle and thymus (3,7). The mice CIDE-A is expressed abundantly in the brown adipose tissue and could be transcriptionally activated by proliferator-activated receptor-alpha (PPARalpha) and PPARgamma (10). Other CIDE genes also have multiple transcripts with different levels of tissue- and cell-specific expression. For example, the human CIDE-B gene is significantly expressed in the liver and spleen tissues (3), while the expression of the human CIDE-C gene was detected in the small intestine, heart, colon and stomach (4). Studies on the human CIDE-B gene showed that the cell-specific expression of two transcripts of CIDE-B was driven by two different promoters through epigenetic and genetic mechanisms (11). The expression of the adipocyte-specific gene FSP27, a member of the mice CIDE family, was regulated by CCAAT/enhancer-binding protein (C/EBP) and other C/EBP-like transcription factors (2). Thus, the transcription of the CIDE genes appears to be regulated in a strictly tissue- and cell-specific manner. However, the molecular mechanisms that regulate the tissue- and cell-specific transcription of the human CIDE-A gene have not been elucidated.
###end p 6
###begin p 7
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 229 235 229 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 305 311 305 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
In the present study, we investigated the transcriptional regulation of the human CIDE-A gene in human tissues and several cancer cells and found that the ubiquitously expressed transcription factors Sp1 and Sp3 were crucial for CIDE-A promoter activity. In addition, we found that DNA methylation of the CIDE-A promoter played an important role in regulating tissue- and cell-specific expression of this gene by interfering with Sp1/Sp3 binding.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
###xml 11 16 <span type="species:ncbi:9606">human</span>
Samples of human tissues and cell lines
###end title 9
###begin p 10
###xml 1017 1018 1010 1011 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
###xml 178 183 <span type="species:ncbi:9606">human</span>
###xml 473 478 <span type="species:ncbi:9606">human</span>
###xml 518 523 <span type="species:ncbi:9606">human</span>
###xml 555 560 <span type="species:ncbi:9606">human</span>
###xml 595 600 <span type="species:ncbi:9606">human</span>
###xml 745 751 <span type="species:ncbi:9913">bovine</span>
###xml 790 795 <span type="species:ncbi:9606">human</span>
Human adipose and liver tissue samples were obtained from Zhongshan Hospital (Shanghai, China). Informed consent was obtained from the patients. The total RNA and genomic DNA of human heart, spleen, kidney, lymph node, lung and stomach tissues were purchased from Shenzhen Innogent Bioscience Inc. All cell lines used in this study were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and were maintained in our laboratory. BEL-7404 cells (human hepatocellular carcinoma), U2OS cells (human osteosarcoma), HEK-293T cells (human embryonic kidney) and Hela cells (human cervical carcinoma) were grown in Dulbecco's modified Eagle's medium (DMEM, Gibco BRL, Grand Island, NY, USA) supplemented with 10% (v/v) fetal bovine serum (FBS, Gibco BRL). Saos-2 cells (human osteosarcoma) were grown in McCoy's 5A medium (Gibco BRL) supplemented with 15% FBS. All media were supplemented with 100 units/ml penicillin and 100 mug/ml streptomycin. All the cells were cultured at 37degreesC in 5% CO2.
###end p 10
###begin title 11
RNA analysis
###end title 11
###begin p 12
###xml 405 411 403 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 427 433 425 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 469 475 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 569 574 567 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 613 618 611 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 651 656 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 722 728 720 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 927 932 895 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
Total RNA was extracted from cultured cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Total RNA (5 mug) was reverse transcribed using oligo(dT)18 primer and SuperScript II First-Strand Synthesis System (Invitrogen) in a reaction volume of 20 mul according to the manufacturer's instructions. PCR was performed using two pairs of primers. The first primer pair was used for amplifying a 305-bp CIDE-A gene fragment (CIDE-A-F, 5'-AAGAGGTCGGGAATAGCGAGAGTC-3'; CIDE-A-R, 5'-CTGCATCCCTATCCACACGTGAACC-3'). The second primer pair was used for amplifying a 532-bp GAPDH gene fragment as an internal control (GAPDH-F, 5'-AGGTCGGAGTCAACGGATTTG-3'; GAPDH-R, 5'-GTGATGGCATGGACTGTGGT-3'). The amplification conditions for CIDE-A were as follows: initial denaturation at 94degreesC for 5 min; 30 cycles of 1 min at 94degreesC, 1 min at 58degreesC and 30 s at 72degreesC; and a final extension step for 10 min at 72degreesC. For GAPDH, the following PCR conditions were applied: 1 cycle at 94degreesC for 5 min; 25 cycles of 1 min at 94degreesC, 1 min at 55degreesC and 1 min at 72degreesC; and a final extension step for 10 min at 72degreesC. The PCR products were electrophoresed on a 1.5% agarose gel.
###end p 12
###begin title 13
CpG island prediction
###end title 13
###begin p 14
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 104 112 <span type="species:ncbi:274808">Searcher</span>
The presence of a putative CpG island in proximity to the CIDE-A gene was analysed using the CpG Island Searcher program () (12) with the default setting (%GC >55%, ObsCpG/ExpCpG >0.65, length >500 bp).
###end p 14
###begin title 15
Plasmid constructs
###end title 15
###begin p 16
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 198 203 <span type="species:ncbi:9606">human</span>
The 5' region (-1556 to -13, relative to the translation start site of the human CIDE-A gene) of human CIDE-A was amplified by PCR using high-fidelity LA Taq polymerase (Takara, Dalian, China) from human genomic DNA isolated from HEK-293T cells and inserted into the pGL3-Basic vector (Promega, Madison, WI, USA). Nested deletions of the CIDE-A promoter region were carried out using the plasmid p(-1556/-13) as the template by PCR amplifications, and the sequences of the products were confirmed by direct sequencing. Primers for nested deletions are: -1556-F (5'-CCCTCGAGCTACAGGTGCTCGCCGTCAT-3'); -1112-F (5'-CCCTCGAGACCACGGTGACCCTTTCTGA-3'); -892-F (5'-CCCTCGAGCCGAGTCCCACCCCTCAACA-3'); -640-F (5'-CCCTCGAGTCACTGTCCCCAAATGCTCA-3'); -438-F (5'-CCCTCGAGGAGGCAAGTGGCGCTCACAT-3'); -250-F (5'-CCCTCGAGGGGCTTCCAAGGTCCTCGGT-3'); -196-F (5'-CCCTCGAGGCTGCGGGAGCCAGGACGAC-3'); -137-F (5'-CCCTCGAGGGAGAGCTCGTGCCAAAACG-3'); -13-R (5'-CCAAGCTTTAGCGGGCCTGGAGGTCTGT-3'); -137-R (5'-CCAAGCTTACCGCCGAGGATCGCGACTT-3')
###end p 16
###begin p 17
###xml 292 299 292 299 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCCGCCC</underline>
###xml 299 301 299 301 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</underline>
###xml 299 301 299 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TT</underline></bold>
###xml 301 302 301 302 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 302 303 302 303 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 302 303 302 303 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 303 305 303 305 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</underline>
###xml 358 360 358 360 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</underline>
###xml 360 361 360 361 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 360 361 360 361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>A</underline></bold>
###xml 361 362 361 362 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 362 364 362 364 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</underline>
###xml 362 364 362 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>AA</underline></bold>
###xml 364 371 364 371 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGGCGGG</underline>
###xml 396 397 396 397 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 397 399 397 399 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</underline>
###xml 397 399 397 399 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TT</underline></bold>
###xml 399 400 399 400 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 400 401 400 401 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 400 401 400 401 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 401 409 401 409 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCCCGCCC</underline>
###xml 462 470 462 470 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGGCGGGG</underline>
###xml 470 471 470 471 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 470 471 470 471 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>A</underline></bold>
###xml 471 472 471 472 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 472 474 472 474 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</underline>
###xml 472 474 472 474 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>AA</underline></bold>
###xml 474 475 474 475 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 500 501 500 501 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 501 503 501 503 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</underline>
###xml 501 503 501 503 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TT</underline></bold>
###xml 503 504 503 504 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 504 505 504 505 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 504 505 504 505 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 505 507 505 507 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</underline>
###xml 507 509 507 509 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</underline>
###xml 507 509 507 509 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TT</underline></bold>
###xml 509 510 509 510 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 510 511 510 511 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 510 511 510 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 511 513 511 513 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</underline>
###xml 566 568 566 568 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</underline>
###xml 568 569 568 569 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 568 569 568 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>A</underline></bold>
###xml 569 570 569 570 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 570 572 570 572 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</underline>
###xml 570 572 570 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>AA</underline></bold>
###xml 572 574 572 574 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</underline>
###xml 574 575 574 575 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 574 575 574 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>A</underline></bold>
###xml 575 576 575 576 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 576 578 576 578 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</underline>
###xml 576 578 576 578 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>AA</underline></bold>
###xml 578 579 578 579 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
Site-directed mutagenesis of two Sp1/Sp3 response elements (RE1, -76/-70; RE2, -70/-64) in plasmid p(-137/-13) was performed by PCR (GGGCGGG in Sp1/Sp3 RE was changed to GGACAAG), and the mutagenesis was confirmed by direct sequencing. Primers for site-directed mutations are: Spm1-R (5'-CGGCCCCGCCCTTGTCCGCCTGCCAGCCCCGCGAA-3'); Spm1-F (5'-TTCGCGGGGCTGGCAGGCGGACAAGGGCGGGGCCG-3'); Spm2-R (5'-CGGCCTTGTCCCCGCCCGCCTGCCAGCCCCGCGAA-3'); Spm2-F (5'-TTCGCGGGGCTGGCAGGCGGGCGGGGACAAGGCCG-3'); Spm3-R (5'-CGGCCTTGTCCTTGTCCGCCTGCCAGCCCCGCGAA-3'); Spm3-F (5'-TTCGCGGGGCTGGCAGGCGGACAAGGACAAGGCCG-3')
###end p 17
###begin title 18
Transfections and luciferase assays
###end title 18
###begin p 19
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
For transient transfections, Hela and HEK-293T cells were plated onto 24-well plates 1 day before transfection at a density of 5 x 104 and 2 x 105 cells/well, respectively. Cells were transfected with 0.4 mug of various luciferase constructs by using LipofectAMINEtrade mark reagent (Gibco BRL) according to the manufacturer's instructions. The pRL-TK plasmid (Promega; 40 ng/sample) containing the Renilla luciferase gene driven by the herpes simplex virus thymidine kinase promoter was cotransfected with the constructs, and the luciferase activity was normalized. The preparation of cell lysates and measurements of luciferase activity were performed using the Dual Reporter assay system (Promega) and Lumat LB 9507 luminometer (EG & G Berthold, Berlin, Germany) according to the manufacturer's instructions. All transfections were performed three times in triplicate.
###end p 19
###begin title 20
Electrophoretic mobility shift assays
###end title 20
###begin p 21
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 238 251 238 251 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGGCGGGGGCGGG</underline>
###xml 276 289 276 289 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCCGCCCCCGCCC</underline>
###xml 451 453 447 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 539 545 535 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 669 671 665 667 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</underline>
###xml 671 672 667 668 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 671 672 667 668 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>A</underline></bold>
###xml 672 673 668 669 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 673 675 669 671 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</underline>
###xml 673 675 669 671 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>AA</underline></bold>
###xml 675 682 671 678 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGGCGGG</underline>
###xml 707 714 703 710 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCCGCCC</underline>
###xml 714 716 710 712 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</underline>
###xml 714 716 710 712 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TT</underline></bold>
###xml 716 717 712 713 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 717 718 713 714 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 717 718 713 714 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 718 720 714 716 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</underline>
###xml 761 769 757 765 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GGGCGGGG</underline>
###xml 769 770 765 766 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 769 770 765 766 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>A</underline></bold>
###xml 770 771 766 767 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 771 773 767 769 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</underline>
###xml 771 773 767 769 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>AA</underline></bold>
###xml 773 774 769 770 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 799 800 795 796 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 800 802 796 798 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</underline>
###xml 800 802 796 798 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TT</underline></bold>
###xml 802 803 798 799 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 803 804 799 800 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 803 804 799 800 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 804 812 800 808 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCCCGCCC</underline>
###xml 853 855 849 851 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</underline>
###xml 855 856 851 852 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 855 856 851 852 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>A</underline></bold>
###xml 856 857 852 853 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 857 859 853 855 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</underline>
###xml 857 859 853 855 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>AA</underline></bold>
###xml 859 861 855 857 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GG</underline>
###xml 861 862 857 858 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</underline>
###xml 861 862 857 858 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>A</underline></bold>
###xml 862 863 858 859 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 863 865 859 861 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AA</underline>
###xml 863 865 859 861 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>AA</underline></bold>
###xml 865 866 861 862 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 891 892 887 888 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 892 894 888 890 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</underline>
###xml 892 894 888 890 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TT</underline></bold>
###xml 894 895 890 891 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 895 896 891 892 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 895 896 891 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 896 898 892 894 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</underline>
###xml 898 900 894 896 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TT</underline>
###xml 898 900 894 896 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TT</underline></bold>
###xml 900 901 896 897 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 901 902 897 898 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 901 902 897 898 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>T</underline></bold>
###xml 902 904 898 900 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CC</underline>
###xml 1153 1154 1147 1148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1494 1496 1482 1484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1353 1359 <span type="species:ncbi:9986">rabbit</span>
###xml 1840 1846 <span type="species:ncbi:9986">rabbit</span>
Nuclear extracts were prepared from Hela cells as described by Gazzoli and Kolodner (13). The wild-type probe of the CIDE-A promoter (from -91 to -57) was generated by annealing two complementary oligonucleotides (SpWT: 5'-GCGGGGCTGGCAGGCGGGCGGGGGCGGGGCCGCCG-3'; 5'-GTGCGGCGGCCCCGCCCCCGCCCGCCTGCCAGCCC-3', the core sequence of the Sp1/Sp3-binding site is underlined) and filling the 3' recessive ends by repair synthesis with dATP, dTTP, dGTP, [alpha-32P]dCTP and the Klenow fragment of DNA polymerase I (Takara). The mutated probe of the CIDE-A promoter was generated by the same procedure, except that several oligonucleotides with mutations (SpM1: 5'-GCGGGGCTGGCAGGCGGACAAGGGCGGGGCCGCCG-3', 5'-GTGCGGCGGCCCCGCCCTTGTCCGCCTGCCAGCCC-3'; SpM2: 5'-GCGGGGCTGGCAGGCGGGCGGGGACAAGGCCGCCG-3', 5'-GTGCGGCGGCCTTGTCCCCGCCCGCCTGCCAGCCC-3'; SpM3: 5'-GCGGGGCTGGCAGGCGGACAAGGACAAGGCCGCCG-3', 5'-GTGCGGCGGCCTTGTCCTTGTCCGCCTGCCAGCCC-3', mutations are shown in bold) in the core sequence of the Sp1/Sp3-binding site were used. Nuclear extracts containing 10 mug of the protein were preincubated in 20 mul of binding buffer [10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1 mM MgCl2, 0.5 mM EDTA, 0.5 mM dithiothreitol, 50 mug/ml poly(dI-dC). poly(dI-dC), and 4% glycerol] with or without unlabeled competitor (100-fold molar excess). For supershift assays, 1 mug of antibodies or rabbit IgG (Sigma) was added to the preincubation mixture. After 30-min preincubation on ice, the DNA probe (20 000 cpm) labeled with [alpha-32P] dCTP was added, and the samples were incubated at room temperature for 30 min. The reaction mixtures were resolved on 4% polyacrylamide gels. The gels were dried and subjected to PhosphorImager analysis using a Storm 860 system and ImageQuant TL software (Amersham Biosciences, Sunnyvale, CA, USA). Antibodies used in supershift assays were rabbit polyclonal antibodies against Sp1 (sc-59X) and Sp3 (sc-644) from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
###end p 21
###begin title 22
Sodium bisulfite genomic sequencing
###end title 22
###begin p 23
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 149 152 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 159 162 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
Sodium bisulfite modification of genomic DNA was performed as described previously (14). Briefly, 2 mug of genomic DNA, which had been digested with EcoRI and BglII, was denatured in 0.3 M NaOH for 15 min at 37degreesC and then treated with 3 M sodium bisulfite (Sigma, St Louis, MO, USA) and 10 mM hydroquinone (Sigma) for 16 h at 50degreesC. The DNA was then desalted using the Wizard DNA Clean-Up System (Promega), desulphonated in 0.3 M NaOH, and precipitated. The treated DNA was amplified by PCR in a 50-mul reaction volume using the bisulfite-specific primers (BS-F, 5'-TTGGTAAGTGATTAAAAGAGATT-3' and BS-R, 5'-CCTAATTATTTCTCCTACATAATC-3'). The amplification conditions for the 325-bp DNA fragment were as follows: 94degreesC for 5 min; 35 cycles of 1 min at 94degreesC, 1 min at 50degreesC, 30 s at 72degreesC; and a final extension step for 10 min at 72degreesC. The purified PCR products were cloned into the pMD18-T vector (Takara), and eight clones were picked out and sequenced for each sample.
###end p 23
###begin title 24
Nuclease accessibility assay
###end title 24
###begin p 25
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 426 429 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 469 475 469 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 612 615 612 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
The nuclei of cells were prepared as described previously (15) and digested with the restriction enzyme AluI (New England Biolabs, Beverly, MA, USA). DNA was then extracted from the digested nuclei with the proteinase K/phenol procedure (16). DNA from the AluI-digested nuclei was amplified by PCR using primers P1 and P3 and electrophoresed on a 2% agarose gel. The absence or presence of a 238-bp fragment indicated whether AluI is accessible to the chromatin in the CIDE-A promoter region. To assess the input of the chromatin, another primer, P2, was also included in the PCR reaction mixture. The amount of AluI-digested chromatin was represented by the ratio 238:113 bp. The primers used were as follows: P1, 5'-GGGCTTCCAAGGTCCTCGGT-3'; P2, 5'- ACCGCCGAGGATCGCGACTT-3'; P3, 5'- TAGCGGGCCTGGAGGTCTGT-3'.
###end p 25
###begin title 26
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
In vitro methylation of the critical CIDE-A promoter region
###end title 26
###begin p 27
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 189 190 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 265 268 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hha</italic>
The CIDE-A reporter construct p(-250/-13) and the pGL3-Basic vector were methylated by incubation with SssI methylase (New England BioLabs) for 3 h at 37degreesC in the presence of 160 muM S-adenosylmethionine. The methylation status was verified by digestion with HhaI, a methylation sensitive enzyme.
###end p 27
###begin title 28
5-aza-2'-Deoxycytidine and trichostatin A treatment
###end title 28
###begin p 29
###xml 166 168 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 169 171 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 246 247 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
Cells were treated with 1 and 10 muM 5-aza-2'-deoxycytidine (5-aza-dC, Sigma) for 72 h or with 300 nM trichostatin A (TSA) (Sigma) for 24 h, as described previously (16,17). Briefly, the cells were plated onto 6-well plates at a density of 2 x 104 at 24 h before treatment. The cells were then treated with 5-aza-dC or TSA. The same volume of dissolving stock was used as a negative control. Due to the chemical instability of 5-aza-dC, fresh inhibitor was added after every 24 h for a total of 72-h incubation.
###end p 29
###begin title 30
Chromatin immunoprecipitation assay
###end title 30
###begin p 31
Chromatin immunoprecipitation (ChIP) assay was performed using the ChIP-IT kit (Active Motif, Carlsbad, CA, USA) according to the manufacturer's protocol. Briefly, cells were treated with 1 muM 5-aza-dC for 3 days, along with a negative control. Formaldehyde was added to the cells at a final concentration of 1% and incubated for 10 min at room temperature. The cells were pelleted, resuspended in SDS lysis buffer (1% SDS/10 mM EDTA/50 mM Tris-HCl, pH 8.1), and incubated on ice. The lysate samples were sonicated, and debris was removed by centrifugation. After obtaining the chromatin solution, salmon sperm DNA-protein G agarose slurry was added and incubated for 2 h at 4degreesC. Beads were pelleted by centrifugation, and the supernatants were incubated overnight at 4degreesC with 2 mug of specific antibodies [anti-Sp1 (sc-59X) and anti-Sp3 (sc-644), Santa Cruz Biotechnology; anti-acetyl-Histone H3 K9 and anti-dimethyl-Histone H3 K9, Upstate Biotechnology, Inc.]. The resultant DNA complexes were collected using a salmon sperm DNA-protein G agarose slurry. After reverse cross-linking of protein-DNA with 5 M NaCl followed by RNase A treatment, DNA was purified using mini-columns provided with the kit. The purified DNA was amplified by the promoter-specific primers (ChIp-F, 5'-GGGCTTCCAAGGTCCTCGGT-3' and ChIp-R, 5'-CACAGCCTCTTAAAGTGCGG-3'), and PCR was performed under the following conditions: 1 cycle at 94degreesC for 5 min; 35 cycles of 1 min at 94degreesC, 1 min at 58degreesC, 30 s at 72degreesC; and a final extension step for 10 min at 72degreesC. The PCR products were analysed by electrophoresis on a 2% agarose gel.
###end p 31
###begin title 32
RNA interference and western blot analysis
###end title 32
###begin p 33
RNA interference was achieved by using siRNA pools of Sp1 and Sp3 (Genepharm Research Shanghai, China). A functional non-targeting siRNA was used as a control for potential non-specific effects caused by siRNA transfection. HEK-293T cells were plated in 6-well dishes and grown to approximately60% confluence. Cells were then transfected using Lipofectamine 2000 according to the manufacturer's protocol (100 nM of each siRNA pool).
###end p 33
###begin p 34
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 593 597 <span type="species:ncbi:9925">goat</span>
###xml 603 609 <span type="species:ncbi:9986">rabbit</span>
###xml 614 620 <span type="species:ncbi:9793">donkey</span>
###xml 626 630 <span type="species:ncbi:9925">goat</span>
###xml 649 660 <span type="species:ncbi:3704">horseradish</span>
Forty-eight hours after transfection, HEK-293T cells were harvested for detection of Sp1 and Sp3 proteins. Total cell samples were harvested by applying 2xSDS Laemmli sample buffer directly on to cell monolayers after three washes with PBS. Electrophoresis, transfer of proteins on to nitrocellulose membranes and blocking of membranes were performed as described previously (18). Antibodies specifically against Sp1 (anti-Sp1, sc-59X), Sp3 (anti-Sp3, sc-644) and tubulin (Ab-4; NeoMarkers, Freemont, CA, USA) were incubated with the membranes for 1 h at room temperature. Secondary antibody [goat anti-rabbit and donkey anti-goat IgG conjugated to horseradish peroxidase (Santa Cruz)] was used at a dilution of 1:2000, and incubated with membranes for 1 h at room temperature. Proteins revealed by western blotting were visualized by chemiluminescence.
###end p 34
###begin title 35
RESULTS
###end title 35
###begin title 36
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Tissue- and cell-specific expression of CIDE-A and the structure of the CIDE-A locus
###end title 36
###begin p 37
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 276 284 276 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 322 328 322 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 605 614 605 614 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 686 692 686 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 700 701 700 701 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 722 728 722 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 905 911 905 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 938 944 938 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 989 994 989 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1051 1052 1051 1052 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1077 1083 1077 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 614 1266 614 1266 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="38">Cell- and tissue-specific expression and genomic structure of the human <italic>CIDE-A</italic> gene. (<bold>A</bold>) RT-PCR analysis of <italic>CIDE-A</italic> expression in five human cell lines and eight human tissues as indicated. Five micrograms of total RNA from cells and tissues was analysed by RT-PCR using primers specific for <italic>CIDE-A</italic> CDS. A 305-bp fragment of <italic>CIDE-A</italic> CDS was amplified. A 532-bp fragment of the <italic>GAPDH</italic> gene was used as a positive control for RNA integrity. (<bold>B</bold>) Structure of the human <italic>CIDE-A</italic> locus. Boxed arrows represent published cDNAs encoding known proteins. The open, grey and black boxes represent the untranslated regions, ORFs and predicted CpG island, respectively.</p>
###xml 614 1266 614 1266 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="38">Cell- and tissue-specific expression and genomic structure of the human <italic>CIDE-A</italic> gene. (<bold>A</bold>) RT-PCR analysis of <italic>CIDE-A</italic> expression in five human cell lines and eight human tissues as indicated. Five micrograms of total RNA from cells and tissues was analysed by RT-PCR using primers specific for <italic>CIDE-A</italic> CDS. A 305-bp fragment of <italic>CIDE-A</italic> CDS was amplified. A 532-bp fragment of the <italic>GAPDH</italic> gene was used as a positive control for RNA integrity. (<bold>B</bold>) Structure of the human <italic>CIDE-A</italic> locus. Boxed arrows represent published cDNAs encoding known proteins. The open, grey and black boxes represent the untranslated regions, ORFs and predicted CpG island, respectively.</p></caption>
###xml 1266 1266 1266 1266 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1028f1"/>
###xml 605 1266 605 1266 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="38">Cell- and tissue-specific expression and genomic structure of the human <italic>CIDE-A</italic> gene. (<bold>A</bold>) RT-PCR analysis of <italic>CIDE-A</italic> expression in five human cell lines and eight human tissues as indicated. Five micrograms of total RNA from cells and tissues was analysed by RT-PCR using primers specific for <italic>CIDE-A</italic> CDS. A 305-bp fragment of <italic>CIDE-A</italic> CDS was amplified. A 532-bp fragment of the <italic>GAPDH</italic> gene was used as a positive control for RNA integrity. (<bold>B</bold>) Structure of the human <italic>CIDE-A</italic> locus. Boxed arrows represent published cDNAs encoding known proteins. The open, grey and black boxes represent the untranslated regions, ORFs and predicted CpG island, respectively.</p></caption><graphic xlink:href="gkm1028f1"/></fig>
###xml 175 180 <span type="species:ncbi:9606">human</span>
###xml 680 685 <span type="species:ncbi:9606">human</span>
###xml 748 753 <span type="species:ncbi:9606">human</span>
###xml 775 780 <span type="species:ncbi:9606">human</span>
###xml 1071 1076 <span type="species:ncbi:9606">human</span>
To confirm that the transcription of the CIDE-A gene is regulated in a cell- and tissue-specific manner, the expression of the CIDE-A gene in five cancer cell lines and eight human tissues was measured by reverse transcription-PCR using the GAPDH gene as an internal control (Figure 1A). A high level of expression of the CIDE-A gene was observed in adipose, lymph node and heart tissues, while no expression was detected in liver, kidney, lung, spleen and stomach tissues. Furthermore, the expression level in HEK-293T and U20S cells was very low and in Hela, BEL-7404 and Saos-2 cells was undetectable. Figure 1.Cell- and tissue-specific expression and genomic structure of the human CIDE-A gene. (A) RT-PCR analysis of CIDE-A expression in five human cell lines and eight human tissues as indicated. Five micrograms of total RNA from cells and tissues was analysed by RT-PCR using primers specific for CIDE-A CDS. A 305-bp fragment of CIDE-A CDS was amplified. A 532-bp fragment of the GAPDH gene was used as a positive control for RNA integrity. (B) Structure of the human CIDE-A locus. Boxed arrows represent published cDNAs encoding known proteins. The open, grey and black boxes represent the untranslated regions, ORFs and predicted CpG island, respectively.
###end p 37
###begin p 38
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 86 87 86 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 291 297 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 324 330 324 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 437 438 437 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 457 462 <span type="species:ncbi:9606">human</span>
Cell- and tissue-specific expression and genomic structure of the human CIDE-A gene. (A) RT-PCR analysis of CIDE-A expression in five human cell lines and eight human tissues as indicated. Five micrograms of total RNA from cells and tissues was analysed by RT-PCR using primers specific for CIDE-A CDS. A 305-bp fragment of CIDE-A CDS was amplified. A 532-bp fragment of the GAPDH gene was used as a positive control for RNA integrity. (B) Structure of the human CIDE-A locus. Boxed arrows represent published cDNAs encoding known proteins. The open, grey and black boxes represent the untranslated regions, ORFs and predicted CpG island, respectively.
###end p 38
###begin p 39
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 61 69 61 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 389 395 389 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 283 291 <span type="species:ncbi:274808">Searcher</span>
The genomic structure of CIDE-A was analysed and is shown in Figure 1B. The gene corresponding to the reported cDNA that encode CIDE-A (GenBank accession number NM_001279) is mapped to chromosome 18p11. The CIDE-A transcript contains 5 exons (exons 1, 2, 3, 4 and 5). The CpG Island Searcher program revealed a CpG island (from -619 to 870) spanning the 5' upstream area and exon 1 of the CIDE-A gene. To simplify the nomenclature, we have attributed position number +1 to the translation start site of the CIDE-A gene.
###end p 39
###begin title 40
###xml 50 56 50 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Identification of the critical promoter region of CIDE-A
###end title 40
###begin p 41
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 387 393 387 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 423 431 423 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 569 577 569 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 888 896 888 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 967 975 967 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 1277 1283 1277 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1365 1371 1365 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1427 1433 1427 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1450 1457 1450 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1459 1468 1459 1468 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 1521 1527 1521 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1535 1536 1535 1536 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1569 1575 1569 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1621 1627 1621 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1961 1967 1961 1967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2283 2284 2281 2282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2313 2319 2311 2317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1468 2491 1468 2489 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">Identification of the minimal promoter region of the <italic>CIDE-A</italic> gene. (<bold>A</bold>) Identification of the critical <italic>CIDE-A</italic> promoter region using luciferase assays. The <italic>CIDE-A</italic> transcripts (open and grey boxes) and CpG island (black box) are indicated. Hela cells (black bars) and HEK-293T cells (grey bars) were transfected with the indicated constructs and assayed for luciferase activity 24 h after transfection. Numbers above the constructs indicate the positions relative to the translation start site of <italic>CIDE-A</italic>. The activity of each promoter construct is shown as the luciferase activity relative to that of the pGL3-Basic vector (a promoterless vector). Values were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid and are shown as means &#177; SD for three independent experiments. (<bold>B</bold>) Nucleotide sequence of the <italic>CIDE-A</italic> minimal promoter region. The E2F and nuclear factor Y response elements are shown in boxes. The consensus sequences for two potential Sp1/Sp3-binding sites are underlined.</p>
###xml 1468 2491 1468 2489 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="42">Identification of the minimal promoter region of the <italic>CIDE-A</italic> gene. (<bold>A</bold>) Identification of the critical <italic>CIDE-A</italic> promoter region using luciferase assays. The <italic>CIDE-A</italic> transcripts (open and grey boxes) and CpG island (black box) are indicated. Hela cells (black bars) and HEK-293T cells (grey bars) were transfected with the indicated constructs and assayed for luciferase activity 24 h after transfection. Numbers above the constructs indicate the positions relative to the translation start site of <italic>CIDE-A</italic>. The activity of each promoter construct is shown as the luciferase activity relative to that of the pGL3-Basic vector (a promoterless vector). Values were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid and are shown as means &#177; SD for three independent experiments. (<bold>B</bold>) Nucleotide sequence of the <italic>CIDE-A</italic> minimal promoter region. The E2F and nuclear factor Y response elements are shown in boxes. The consensus sequences for two potential Sp1/Sp3-binding sites are underlined.</p></caption>
###xml 2491 2491 2489 2489 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1028f2"/>
###xml 1459 2491 1459 2489 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="42">Identification of the minimal promoter region of the <italic>CIDE-A</italic> gene. (<bold>A</bold>) Identification of the critical <italic>CIDE-A</italic> promoter region using luciferase assays. The <italic>CIDE-A</italic> transcripts (open and grey boxes) and CpG island (black box) are indicated. Hela cells (black bars) and HEK-293T cells (grey bars) were transfected with the indicated constructs and assayed for luciferase activity 24 h after transfection. Numbers above the constructs indicate the positions relative to the translation start site of <italic>CIDE-A</italic>. The activity of each promoter construct is shown as the luciferase activity relative to that of the pGL3-Basic vector (a promoterless vector). Values were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid and are shown as means &#177; SD for three independent experiments. (<bold>B</bold>) Nucleotide sequence of the <italic>CIDE-A</italic> minimal promoter region. The E2F and nuclear factor Y response elements are shown in boxes. The consensus sequences for two potential Sp1/Sp3-binding sites are underlined.</p></caption><graphic xlink:href="gkm1028f2"/></fig>
To investigate the transcriptional regulation of the CIDE-A gene, we identified the promoter region of this gene. We first constructed a luciferase reporter plasmid p(-1556/-13) that contained a 1544-bp genomic DNA fragment spanning the 5' upstream region of CIDE-A. This plasmid was used for transient transfection of Hela and HEK-293T cells. HEK-293T cells expressed very low level of CIDE-A, whereas Hela cells did not (Figure 1A). The cloned fragment exhibited obvious promoter activity in both cell lines, indicating that an active promoter sequence was isolated (Figure 2A). Next, we developed a series of deletion constructs to identify the minimal promoter required for activation. Deletion in the 3' region from -13 to -137 completely abolished the activity of the reporter gene and enabled to locate the minimal promoter within the 125-bp region between positions -137 and -13 (Figure 2A). The nucleotide sequence of the minimal promoter region is shown in Figure 2B and deposited in GenBank under the accession number . This sequence is located in the CpG island. We searched for transcription factor binding sites using the MatInspector program and found consensus sequences for the binding of Sp1/Sp3, E2F and Nuclear factor Y. Although Hela cells did not express CIDE-A, the different constructs exhibited obvious promoter activity, regardless of the CIDE-A expression status, suggesting additional mechanisms of CIDE-A gene regulation in vivo. Figure 2.Identification of the minimal promoter region of the CIDE-A gene. (A) Identification of the critical CIDE-A promoter region using luciferase assays. The CIDE-A transcripts (open and grey boxes) and CpG island (black box) are indicated. Hela cells (black bars) and HEK-293T cells (grey bars) were transfected with the indicated constructs and assayed for luciferase activity 24 h after transfection. Numbers above the constructs indicate the positions relative to the translation start site of CIDE-A. The activity of each promoter construct is shown as the luciferase activity relative to that of the pGL3-Basic vector (a promoterless vector). Values were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid and are shown as means +/- SD for three independent experiments. (B) Nucleotide sequence of the CIDE-A minimal promoter region. The E2F and nuclear factor Y response elements are shown in boxes. The consensus sequences for two potential Sp1/Sp3-binding sites are underlined.
###end p 41
###begin p 42
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 101 107 101 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 153 159 153 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 493 499 493 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 815 816 813 814 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 845 851 843 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Identification of the minimal promoter region of the CIDE-A gene. (A) Identification of the critical CIDE-A promoter region using luciferase assays. The CIDE-A transcripts (open and grey boxes) and CpG island (black box) are indicated. Hela cells (black bars) and HEK-293T cells (grey bars) were transfected with the indicated constructs and assayed for luciferase activity 24 h after transfection. Numbers above the constructs indicate the positions relative to the translation start site of CIDE-A. The activity of each promoter construct is shown as the luciferase activity relative to that of the pGL3-Basic vector (a promoterless vector). Values were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid and are shown as means +/- SD for three independent experiments. (B) Nucleotide sequence of the CIDE-A minimal promoter region. The E2F and nuclear factor Y response elements are shown in boxes. The consensus sequences for two potential Sp1/Sp3-binding sites are underlined.
###end p 42
###begin title 43
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Sp1/Sp3-binding motifs are important for CIDE-A promoter activity
###end title 43
###begin p 44
###xml 12 20 12 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 713 721 701 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 829 835 817 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 854 863 842 851 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 904 910 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 986 992 974 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 863 1366 851 1352 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="45">Sp1/Sp3-binding motifs are important for <italic>CIDE-A</italic> promoter activity. The effect of Sp1/Sp3-binding site on the regulation of <italic>CIDE-A</italic> promoter activity is shown. Values of luciferase activities due to the wild-type construct p(&#8722;137/&#8722;13) and the mutated constructs (Spm1, Spm2 and Spm3) in Hela cells (black bars) and HEK-293T cells (grey bars) are shown as means &#177; SD for three independent experiments, each of which was performed using triplicate samples. Mutations are shown in bold above the histogram.</p>
###xml 863 1366 851 1352 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="45">Sp1/Sp3-binding motifs are important for <italic>CIDE-A</italic> promoter activity. The effect of Sp1/Sp3-binding site on the regulation of <italic>CIDE-A</italic> promoter activity is shown. Values of luciferase activities due to the wild-type construct p(&#8722;137/&#8722;13) and the mutated constructs (Spm1, Spm2 and Spm3) in Hela cells (black bars) and HEK-293T cells (grey bars) are shown as means &#177; SD for three independent experiments, each of which was performed using triplicate samples. Mutations are shown in bold above the histogram.</p></caption>
###xml 1366 1366 1352 1352 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1028f3"/>
###xml 854 1366 842 1352 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="45">Sp1/Sp3-binding motifs are important for <italic>CIDE-A</italic> promoter activity. The effect of Sp1/Sp3-binding site on the regulation of <italic>CIDE-A</italic> promoter activity is shown. Values of luciferase activities due to the wild-type construct p(&#8722;137/&#8722;13) and the mutated constructs (Spm1, Spm2 and Spm3) in Hela cells (black bars) and HEK-293T cells (grey bars) are shown as means &#177; SD for three independent experiments, each of which was performed using triplicate samples. Mutations are shown in bold above the histogram.</p></caption><graphic xlink:href="gkm1028f3"/></fig>
As shown in Figure 2B, two putative binding sites for Sp1/Sp3 were found in the minimal promoter region of CIDE-A. To determine whether the Sp1/Sp3-binding elements are important in CIDE-A promoter activity, we generated several constructs of p(-137/-13) that contained mutations in the Sp1/Sp3-binding site by site-directed mutagenesis. The reporter constructs containing mutated sequences were then transfected into Hela and HEK-293T cells and assayed for promoter activities. The mutation induced in either of the Sp1/Sp3 sites decreased the promoter activity level to approximately50% of that of the wild type, whereas the activity decreased to a basal level when both the Sp1/Sp3-binding sites were mutated (Figure 3). These results clearly indicate that both the Sp1/Sp3-binding sites are essential for the activity of the CIDE-A minimal promoter. Figure 3.Sp1/Sp3-binding motifs are important for CIDE-A promoter activity. The effect of Sp1/Sp3-binding site on the regulation of CIDE-A promoter activity is shown. Values of luciferase activities due to the wild-type construct p(-137/-13) and the mutated constructs (Spm1, Spm2 and Spm3) in Hela cells (black bars) and HEK-293T cells (grey bars) are shown as means +/- SD for three independent experiments, each of which was performed using triplicate samples. Mutations are shown in bold above the histogram.
###end p 44
###begin p 45
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 123 129 123 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Sp1/Sp3-binding motifs are important for CIDE-A promoter activity. The effect of Sp1/Sp3-binding site on the regulation of CIDE-A promoter activity is shown. Values of luciferase activities due to the wild-type construct p(-137/-13) and the mutated constructs (Spm1, Spm2 and Spm3) in Hela cells (black bars) and HEK-293T cells (grey bars) are shown as means +/- SD for three independent experiments, each of which was performed using triplicate samples. Mutations are shown in bold above the histogram.
###end p 45
###begin title 46
###xml 69 75 69 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Determination of the specific binding of Sp1 and Sp3 to the critical CIDE-A promoter region
###end title 46
###begin p 47
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 150 152 146 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 351 359 347 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 473 481 469 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 865 873 861 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 945 951 941 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1124 1132 1120 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1221 1229 1217 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1334 1342 1330 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1459 1465 1455 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1484 1493 1480 1489 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1541 1547 1537 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1599 1605 1595 1601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1695 1697 1691 1693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1991 1993 1987 1989 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2290 2292 2286 2288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 2518 2520 2513 2515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1493 2546 1489 2541 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">Specific binding of Sp1 and Sp3 to the critical <italic>CIDE-A</italic> promoter region. The binding of Sp1 and Sp3 to the <italic>CIDE-A</italic> core promoter was determined by electrophoretic mobility shift analysis (EMSA). By using <sup>32</sup>P-labeled 35-bp double-stranded oligonucleotides containing wild or mutated Sp1/Sp3-binding sites as probes, EMSAs were performed with the same amount of nuclear extracts (NE) from Hela cells, and the products were separated on a 4% polyacrylamide gel (lanes 2&#8211;10). Lane 1, free probe; lane 2, <sup>32</sup>P-labeled wild-type Sp1/Sp3 consensus oligonucleotides were mixed with nuclear proteins; lane 3, the same reaction was performed as that in lane 2, except for the presence of a 100-fold excess of unlabeled wild-type Sp1/Sp3 consensus oligonucleotides as a competitor; lanes 4&#8211;6, binding assays of <sup>32</sup>P-labeled mutant-type Sp1/Sp3 consensus oligonucleotides mixed with nuclear proteins; lanes 7&#8211;10, 1 &#956;g each of IgG, anti-Sp1, anti-Sp3 or both anti-Sp1 and anti-Sp3 antibodies were added to the binding reaction mixtures with <sup>32</sup>P-labeled wild-type probe.</p>
###xml 1493 2546 1489 2541 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">Specific binding of Sp1 and Sp3 to the critical <italic>CIDE-A</italic> promoter region. The binding of Sp1 and Sp3 to the <italic>CIDE-A</italic> core promoter was determined by electrophoretic mobility shift analysis (EMSA). By using <sup>32</sup>P-labeled 35-bp double-stranded oligonucleotides containing wild or mutated Sp1/Sp3-binding sites as probes, EMSAs were performed with the same amount of nuclear extracts (NE) from Hela cells, and the products were separated on a 4% polyacrylamide gel (lanes 2&#8211;10). Lane 1, free probe; lane 2, <sup>32</sup>P-labeled wild-type Sp1/Sp3 consensus oligonucleotides were mixed with nuclear proteins; lane 3, the same reaction was performed as that in lane 2, except for the presence of a 100-fold excess of unlabeled wild-type Sp1/Sp3 consensus oligonucleotides as a competitor; lanes 4&#8211;6, binding assays of <sup>32</sup>P-labeled mutant-type Sp1/Sp3 consensus oligonucleotides mixed with nuclear proteins; lanes 7&#8211;10, 1 &#956;g each of IgG, anti-Sp1, anti-Sp3 or both anti-Sp1 and anti-Sp3 antibodies were added to the binding reaction mixtures with <sup>32</sup>P-labeled wild-type probe.</p></caption>
###xml 2546 2546 2541 2541 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1028f4"/>
###xml 1484 2546 1480 2541 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="48">Specific binding of Sp1 and Sp3 to the critical <italic>CIDE-A</italic> promoter region. The binding of Sp1 and Sp3 to the <italic>CIDE-A</italic> core promoter was determined by electrophoretic mobility shift analysis (EMSA). By using <sup>32</sup>P-labeled 35-bp double-stranded oligonucleotides containing wild or mutated Sp1/Sp3-binding sites as probes, EMSAs were performed with the same amount of nuclear extracts (NE) from Hela cells, and the products were separated on a 4% polyacrylamide gel (lanes 2&#8211;10). Lane 1, free probe; lane 2, <sup>32</sup>P-labeled wild-type Sp1/Sp3 consensus oligonucleotides were mixed with nuclear proteins; lane 3, the same reaction was performed as that in lane 2, except for the presence of a 100-fold excess of unlabeled wild-type Sp1/Sp3 consensus oligonucleotides as a competitor; lanes 4&#8211;6, binding assays of <sup>32</sup>P-labeled mutant-type Sp1/Sp3 consensus oligonucleotides mixed with nuclear proteins; lanes 7&#8211;10, 1 &#956;g each of IgG, anti-Sp1, anti-Sp3 or both anti-Sp1 and anti-Sp3 antibodies were added to the binding reaction mixtures with <sup>32</sup>P-labeled wild-type probe.</p></caption><graphic xlink:href="gkm1028f4"/></fig>
To directly demonstrate that Sp1 and Sp3 bind to the putative binding site within the critical CIDE-A promoter region, EMSA was performed using alpha-32P-labeled oligonucleotides spanning the two putative Sp1/Sp3-binding sites with nuclear extracts generated from Hela cells. Shifted complexes were observed when the labeled wild-type probe was used (Figure 4, lane 2); these complexes were eliminated by the addition of 100-fold molar excess of unlabeled wild-type probe (Figure 4, lane 3). EMSA was also performed on mutant probes to understand the contribution of each of the Sp1/Sp3-binding sites to the observed binding patterns. Any mutation in the two Sp1/Sp3-binding sites (SpM1 or SpM2 probe) slightly decreased the level of complex formation, while these bands were not observed when using the SpM3 probe with mutations in both the Sp1/Sp3-binding sites (Figure 4, lanes 4-6). To further confirm the specific binding of Sp1/Sp3 to the CIDE-A minimal promoter, supershift assay was performed using anti-Sp1 and anti-Sp3 antibodies. The slowest migrating protein-DNA complex was supershifted by anti-Sp1 antibodies (Figure 4, lane 8), whereas the rapidly migrating bands were supershifted by anti-Sp3 antibodies (Figure 4, lane 9). However, no supershift was observed when control IgG was used instead of specific antibodies (Figure 4, lane 7). The EMSA results demonstrated that Sp1 and Sp3 bound specifically to the two Sp1/Sp3-binding sites in the CIDE-A minimal promoter. Figure 4.Specific binding of Sp1 and Sp3 to the critical CIDE-A promoter region. The binding of Sp1 and Sp3 to the CIDE-A core promoter was determined by electrophoretic mobility shift analysis (EMSA). By using 32P-labeled 35-bp double-stranded oligonucleotides containing wild or mutated Sp1/Sp3-binding sites as probes, EMSAs were performed with the same amount of nuclear extracts (NE) from Hela cells, and the products were separated on a 4% polyacrylamide gel (lanes 2-10). Lane 1, free probe; lane 2, 32P-labeled wild-type Sp1/Sp3 consensus oligonucleotides were mixed with nuclear proteins; lane 3, the same reaction was performed as that in lane 2, except for the presence of a 100-fold excess of unlabeled wild-type Sp1/Sp3 consensus oligonucleotides as a competitor; lanes 4-6, binding assays of 32P-labeled mutant-type Sp1/Sp3 consensus oligonucleotides mixed with nuclear proteins; lanes 7-10, 1 mug each of IgG, anti-Sp1, anti-Sp3 or both anti-Sp1 and anti-Sp3 antibodies were added to the binding reaction mixtures with 32P-labeled wild-type probe.
###end p 47
###begin p 48
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 202 204 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 498 500 498 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 797 799 797 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1025 1027 1024 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Specific binding of Sp1 and Sp3 to the critical CIDE-A promoter region. The binding of Sp1 and Sp3 to the CIDE-A core promoter was determined by electrophoretic mobility shift analysis (EMSA). By using 32P-labeled 35-bp double-stranded oligonucleotides containing wild or mutated Sp1/Sp3-binding sites as probes, EMSAs were performed with the same amount of nuclear extracts (NE) from Hela cells, and the products were separated on a 4% polyacrylamide gel (lanes 2-10). Lane 1, free probe; lane 2, 32P-labeled wild-type Sp1/Sp3 consensus oligonucleotides were mixed with nuclear proteins; lane 3, the same reaction was performed as that in lane 2, except for the presence of a 100-fold excess of unlabeled wild-type Sp1/Sp3 consensus oligonucleotides as a competitor; lanes 4-6, binding assays of 32P-labeled mutant-type Sp1/Sp3 consensus oligonucleotides mixed with nuclear proteins; lanes 7-10, 1 mug each of IgG, anti-Sp1, anti-Sp3 or both anti-Sp1 and anti-Sp3 antibodies were added to the binding reaction mixtures with 32P-labeled wild-type probe.
###end p 48
###begin title 49
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Methylation status of CpG sites in the CIDE-A promoter
###end title 49
###begin p 50
###xml 155 161 155 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 216 224 216 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 481 487 481 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 605 613 605 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 679 685 679 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 855 861 831 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 971 977 947 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1140 1146 1116 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1195 1201 1171 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1393 1399 1369 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1712 1718 1676 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1750 1758 1714 1722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1803 1809 1767 1773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2363 2371 2315 2323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 2435 2441 2387 2393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2461 2470 2413 2422 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 2509 2515 2461 2467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2527 2528 2479 2480 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 2555 2561 2507 2513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2651 2657 2603 2609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2663 2669 2615 2621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2823 2824 2775 2776 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2854 2860 2806 2812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 3369 3370 3321 3322 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 3382 3390 3334 3342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 3426 3432 3378 3384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 3447 3453 3399 3405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 3509 3517 3461 3469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2470 3900 2422 3850 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="51">Methylation status of CpG sites in the <italic>CIDE-A</italic> promoter. (<bold>A</bold>) Schematic diagram of the <italic>CIDE-A</italic> gene 5&#8242; region. Numbers indicate the positions relative to the translation start site of <italic>CIDE-A</italic>. The <italic>CIDE-A</italic> minimal promoter is indicated by the grey box. The position of the 31 CpG sites detected by bisulfite sequencing is indicated by a short vertical line. (<bold>B</bold>) Bisulfite sequencing of the <italic>CIDE-A</italic> promoter region. The genomic DNA from BEL-7404, Hela and HEK-293T cells and from the liver, spleen, stomach, heart and adipose tissues was treated with bisulfite and amplified by PCR. The PCR products were then subcloned and sequenced. For each cell line and tissue, the methylation status of 31 CpGs in the promoter region is shown for eight clones. White and black circles indicate unmethylated and methylated CpGs, respectively. Circles enclosed by boxes represent the CpGs in the Sp1/Sp3-binding sites. (<bold>C</bold>) Effect of <italic>in vitro</italic> methylation on the activity of the <italic>CIDE-A</italic> promoter. The <italic>CIDE-A</italic> promoter-luciferase plasmid p(&#8722;250/&#8722;13) was methylated <italic>in vitro</italic> by SssI methylase. Methylated and unmethylated p(&#8722;250/&#8722;13) were then transiently transfected into Hela and HEK-293T cells and assayed for luciferase activity. Results are shown as percentages of luciferase activity, with the activity due to unmethylated p(&#8722;250/&#8722;13) considered as 100%. The average &#177; SD values from three independent experiments performed in triplicates are shown.</p>
###xml 2470 3900 2422 3850 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="51">Methylation status of CpG sites in the <italic>CIDE-A</italic> promoter. (<bold>A</bold>) Schematic diagram of the <italic>CIDE-A</italic> gene 5&#8242; region. Numbers indicate the positions relative to the translation start site of <italic>CIDE-A</italic>. The <italic>CIDE-A</italic> minimal promoter is indicated by the grey box. The position of the 31 CpG sites detected by bisulfite sequencing is indicated by a short vertical line. (<bold>B</bold>) Bisulfite sequencing of the <italic>CIDE-A</italic> promoter region. The genomic DNA from BEL-7404, Hela and HEK-293T cells and from the liver, spleen, stomach, heart and adipose tissues was treated with bisulfite and amplified by PCR. The PCR products were then subcloned and sequenced. For each cell line and tissue, the methylation status of 31 CpGs in the promoter region is shown for eight clones. White and black circles indicate unmethylated and methylated CpGs, respectively. Circles enclosed by boxes represent the CpGs in the Sp1/Sp3-binding sites. (<bold>C</bold>) Effect of <italic>in vitro</italic> methylation on the activity of the <italic>CIDE-A</italic> promoter. The <italic>CIDE-A</italic> promoter-luciferase plasmid p(&#8722;250/&#8722;13) was methylated <italic>in vitro</italic> by SssI methylase. Methylated and unmethylated p(&#8722;250/&#8722;13) were then transiently transfected into Hela and HEK-293T cells and assayed for luciferase activity. Results are shown as percentages of luciferase activity, with the activity due to unmethylated p(&#8722;250/&#8722;13) considered as 100%. The average &#177; SD values from three independent experiments performed in triplicates are shown.</p></caption>
###xml 3900 3900 3850 3850 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1028f5"/>
###xml 2461 3900 2413 3850 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="51">Methylation status of CpG sites in the <italic>CIDE-A</italic> promoter. (<bold>A</bold>) Schematic diagram of the <italic>CIDE-A</italic> gene 5&#8242; region. Numbers indicate the positions relative to the translation start site of <italic>CIDE-A</italic>. The <italic>CIDE-A</italic> minimal promoter is indicated by the grey box. The position of the 31 CpG sites detected by bisulfite sequencing is indicated by a short vertical line. (<bold>B</bold>) Bisulfite sequencing of the <italic>CIDE-A</italic> promoter region. The genomic DNA from BEL-7404, Hela and HEK-293T cells and from the liver, spleen, stomach, heart and adipose tissues was treated with bisulfite and amplified by PCR. The PCR products were then subcloned and sequenced. For each cell line and tissue, the methylation status of 31 CpGs in the promoter region is shown for eight clones. White and black circles indicate unmethylated and methylated CpGs, respectively. Circles enclosed by boxes represent the CpGs in the Sp1/Sp3-binding sites. (<bold>C</bold>) Effect of <italic>in vitro</italic> methylation on the activity of the <italic>CIDE-A</italic> promoter. The <italic>CIDE-A</italic> promoter-luciferase plasmid p(&#8722;250/&#8722;13) was methylated <italic>in vitro</italic> by SssI methylase. Methylated and unmethylated p(&#8722;250/&#8722;13) were then transiently transfected into Hela and HEK-293T cells and assayed for luciferase activity. Results are shown as percentages of luciferase activity, with the activity due to unmethylated p(&#8722;250/&#8722;13) considered as 100%. The average &#177; SD values from three independent experiments performed in triplicates are shown.</p></caption><graphic xlink:href="gkm1028f5"/></fig>
Sp1 and Sp3 are ubiquitously expressed transcription factors; therefore, they might not be responsible for the tissue- and cell-specific expression of the CIDE-A gene. The CIDE-A promoter is located in a CpG island (Figure 5A), and the Sp1/Sp3-binding sites in the CIDE-A gene promoter contain a CpG dinucleotide, a potential target for DNA methylation in mammals; this suggests that DNA methylation may play a role in the regulation of tissue- and cell-specific expression of the CIDE-A gene. We then examined the methylation status of 31 CpG sites in the promoter region by sodium bisulfite sequencing (Figure 5B). The results from the sequences of eight clones showed that in CIDE-A expressed tissues the overall percentage of methylated CpG sites was very low, only approximately7% in adipose and approximately9% in heart, indicating the CpG sites in CIDE-A promoter region were unmethylated in adipose and heart tissues; In contrast, in tissues that did not express CIDE-A (liver, spleen and stomach), the percentage of methylated CpG sites was higher, about 73%, 63% and 57%, respectively, indicating the hypermethylated CpG sites in CIDE-A absent expressed tissues. In the cells in which CIDE-A was silenced (Hela and BEL-7404), a high degree of methylation was observed at each CpG site, including the Sp1/Sp3-binding sites. However, in HEK-293T cells, that with a lower expression of CIDE-A, the methylation patterns were more mosaic, in eight clones sequenced we detected one clone with lower percentage of methylation (approximately55%) and other clones were fully methylated. These results revealed that the methylation status of the CpG dinucleotide reflected the tissue and cell specificity of the CIDE-A gene expression. The effect of in vitro methylation on the promoter activity of the CIDE-A gene was then investigated through transient transfection of CpG-methylated reporter plasmids into HEK-293T and Hela cells. We modified the promoter constructs with SssI methylase and studied the activity of the methylated promoter. The luciferase activities of CpG-methylated reporter plasmids were calculated relative to those of unmethylated plasmids (unmethylated controls). The luciferase activity of SssI-methylated pGL3-(-250/-13) decreased to approximately5% and 4% of that of the unmethylated controls in HEK-293T and Hela cells, respectively (Figure 5C), suggesting a direct association between CpG methylation and CIDE-A promoter activity. Figure 5.Methylation status of CpG sites in the CIDE-A promoter. (A) Schematic diagram of the CIDE-A gene 5' region. Numbers indicate the positions relative to the translation start site of CIDE-A. The CIDE-A minimal promoter is indicated by the grey box. The position of the 31 CpG sites detected by bisulfite sequencing is indicated by a short vertical line. (B) Bisulfite sequencing of the CIDE-A promoter region. The genomic DNA from BEL-7404, Hela and HEK-293T cells and from the liver, spleen, stomach, heart and adipose tissues was treated with bisulfite and amplified by PCR. The PCR products were then subcloned and sequenced. For each cell line and tissue, the methylation status of 31 CpGs in the promoter region is shown for eight clones. White and black circles indicate unmethylated and methylated CpGs, respectively. Circles enclosed by boxes represent the CpGs in the Sp1/Sp3-binding sites. (C) Effect of in vitro methylation on the activity of the CIDE-A promoter. The CIDE-A promoter-luciferase plasmid p(-250/-13) was methylated in vitro by SssI methylase. Methylated and unmethylated p(-250/-13) were then transiently transfected into Hela and HEK-293T cells and assayed for luciferase activity. Results are shown as percentages of luciferase activity, with the activity due to unmethylated p(-250/-13) considered as 100%. The average +/- SD values from three independent experiments performed in triplicates are shown.
###end p 50
###begin p 51
###xml 39 45 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 57 58 57 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 85 91 85 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 181 187 181 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 193 199 193 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 353 354 353 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 899 900 899 900 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 912 920 912 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 956 962 956 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 977 983 977 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1039 1047 1039 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Methylation status of CpG sites in the CIDE-A promoter. (A) Schematic diagram of the CIDE-A gene 5' region. Numbers indicate the positions relative to the translation start site of CIDE-A. The CIDE-A minimal promoter is indicated by the grey box. The position of the 31 CpG sites detected by bisulfite sequencing is indicated by a short vertical line. (B) Bisulfite sequencing of the CIDE-A promoter region. The genomic DNA from BEL-7404, Hela and HEK-293T cells and from the liver, spleen, stomach, heart and adipose tissues was treated with bisulfite and amplified by PCR. The PCR products were then subcloned and sequenced. For each cell line and tissue, the methylation status of 31 CpGs in the promoter region is shown for eight clones. White and black circles indicate unmethylated and methylated CpGs, respectively. Circles enclosed by boxes represent the CpGs in the Sp1/Sp3-binding sites. (C) Effect of in vitro methylation on the activity of the CIDE-A promoter. The CIDE-A promoter-luciferase plasmid p(-250/-13) was methylated in vitro by SssI methylase. Methylated and unmethylated p(-250/-13) were then transiently transfected into Hela and HEK-293T cells and assayed for luciferase activity. Results are shown as percentages of luciferase activity, with the activity due to unmethylated p(-250/-13) considered as 100%. The average +/- SD values from three independent experiments performed in triplicates are shown.
###end p 51
###begin title 52
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Induction of CIDE-A gene expression by 5-aza-dC
###end title 52
###begin p 53
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 203 209 203 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 317 325 316 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 515 521 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 803 809 801 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 898 906 896 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1054 1060 1052 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1223 1229 1221 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1304 1313 1302 1311 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1330 1336 1328 1334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1367 1368 1365 1366 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1578 1584 1575 1581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1590 1595 1587 1592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1652 1653 1649 1650 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1728 1734 1725 1731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1313 1851 1311 1848 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="54">Induction of the <italic>CIDE-A</italic> gene expression by 5-aza-dC. (<bold>A</bold>) HEK-293T, Hela and BEL-7404 cells were treated with 1 or 10 &#956;M 5-aza-dC. Seventy-two hours after 5-aza-dC treatment, total RNA was isolated from treated or untreated cells and subjected to RT-PCR to amplify <italic>CIDE-A</italic>. The <italic>GAPDH</italic> gene was used as a positive control for RNA integrity. (<bold>B</bold>) Bisulfite sequencing to determine the methylation status of the critical <italic>CIDE-A</italic> promoter region after 5-aza-dC treatment. Circles enclosed by boxes represent the CpGs in the Sp1/Sp3-binding sites.</p>
###xml 1313 1851 1311 1848 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="54">Induction of the <italic>CIDE-A</italic> gene expression by 5-aza-dC. (<bold>A</bold>) HEK-293T, Hela and BEL-7404 cells were treated with 1 or 10 &#956;M 5-aza-dC. Seventy-two hours after 5-aza-dC treatment, total RNA was isolated from treated or untreated cells and subjected to RT-PCR to amplify <italic>CIDE-A</italic>. The <italic>GAPDH</italic> gene was used as a positive control for RNA integrity. (<bold>B</bold>) Bisulfite sequencing to determine the methylation status of the critical <italic>CIDE-A</italic> promoter region after 5-aza-dC treatment. Circles enclosed by boxes represent the CpGs in the Sp1/Sp3-binding sites.</p></caption>
###xml 1851 1851 1848 1848 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1028f6"/>
###xml 1304 1851 1302 1848 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="54">Induction of the <italic>CIDE-A</italic> gene expression by 5-aza-dC. (<bold>A</bold>) HEK-293T, Hela and BEL-7404 cells were treated with 1 or 10 &#956;M 5-aza-dC. Seventy-two hours after 5-aza-dC treatment, total RNA was isolated from treated or untreated cells and subjected to RT-PCR to amplify <italic>CIDE-A</italic>. The <italic>GAPDH</italic> gene was used as a positive control for RNA integrity. (<bold>B</bold>) Bisulfite sequencing to determine the methylation status of the critical <italic>CIDE-A</italic> promoter region after 5-aza-dC treatment. Circles enclosed by boxes represent the CpGs in the Sp1/Sp3-binding sites.</p></caption><graphic xlink:href="gkm1028f6"/></fig>
To confirm the role of DNA methylation in the CIDE-A minimal promoter in silencing gene expression, two CIDE-A-negative cell lines, i.e. Hela and BEL-7404, and one cell line with low-level expression of CIDE-A, i.e. HEK-293T, were treated with the DNA methyltransferase inhibitor 5-aza-dC (1 and 10 muM). As shown in Figure 6A, CIDE-A expression was induced in Hela and BEL-7404 cells after 72 h of exposure to the reagent, while the expression in HEK-293T cells was also increased significantly. The expression of CIDE-A was induced at a similar level following treatment with 5-aza-dC at 1 and 10 muM concentrations. The methylation status in Hela, BEL-7404 and HEK-293T cells after 5-aza-dC treatment was then determined by sodium bisulfite sequencing. Methylation was significantly decreased in the CIDE-A critical promoter region in Hela, BEL-7404 and HEK-293T cells after 5-aza-dC treatment (Figure 6B). The non-expressing cell lines Hela and BEL-7404 were also treated with 300 nM TSA, a histone deacetylase inhibitor. No significant induction of CIDE-A expression was detected by reverse transcription-PCR (data not shown), suggesting that histone deacetylase inhibition by TSA was not sufficient to reactivate the CIDE-A gene that was silenced following hypermethylation of the promoter region. Figure 6.Induction of the CIDE-A gene expression by 5-aza-dC. (A) HEK-293T, Hela and BEL-7404 cells were treated with 1 or 10 muM 5-aza-dC. Seventy-two hours after 5-aza-dC treatment, total RNA was isolated from treated or untreated cells and subjected to RT-PCR to amplify CIDE-A. The GAPDH gene was used as a positive control for RNA integrity. (B) Bisulfite sequencing to determine the methylation status of the critical CIDE-A promoter region after 5-aza-dC treatment. Circles enclosed by boxes represent the CpGs in the Sp1/Sp3-binding sites.
###end p 53
###begin p 54
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 54 55 54 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 265 271 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 277 282 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 339 340 338 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 415 421 414 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Induction of the CIDE-A gene expression by 5-aza-dC. (A) HEK-293T, Hela and BEL-7404 cells were treated with 1 or 10 muM 5-aza-dC. Seventy-two hours after 5-aza-dC treatment, total RNA was isolated from treated or untreated cells and subjected to RT-PCR to amplify CIDE-A. The GAPDH gene was used as a positive control for RNA integrity. (B) Bisulfite sequencing to determine the methylation status of the critical CIDE-A promoter region after 5-aza-dC treatment. Circles enclosed by boxes represent the CpGs in the Sp1/Sp3-binding sites.
###end p 54
###begin title 55
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
5-aza-dC treatment changes the chromatin conformation around the CIDE-A promoter
###end title 55
###begin p 56
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 368 371 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 397 403 397 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 414 422 414 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 538 541 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 576 579 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 848 856 847 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 905 911 904 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 980 989 979 988 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7.</label>
###xml 1054 1060 1053 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1072 1073 1071 1072 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1167 1170 1166 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1317 1320 1316 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1378 1381 1377 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 1385 1386 1384 1385 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1436 1442 1435 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1611 1612 1610 1611 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1614 1621 1613 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 1672 1678 1671 1677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 989 1981 988 1980 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="57">5-aza-dC treatment changes the chromatin conformation around the <italic>CIDE-A</italic> promoter. (<bold>A</bold>) Procedure of nuclease accessibility assay. Nuclei were digested with the restriction enzyme <italic>Alu</italic>I. DNA was extracted from the nuclei and amplified by PCR using a set of three primers (P1, P2 and P3). The decrease in the ratio 238:113 bp after <italic>Alu</italic>I digestion indicates that the chromatin is accessible to <italic>Alu</italic>I. (<bold>B</bold>) Chromatin accessibility changes in the critical <italic>CIDE-A</italic> promoter region in Hela, HEK-293T and BEL-7404 cells following treatment with 5-aza-dC. The ratio decreased significantly after treating with 1 M 5-aza-dC for 3 days. (<bold>C</bold>) <italic>In vivo</italic> H3K9 di-methylation and acetylation levels in the <italic>CIDE-A</italic> core promoter before and after 3 days&#8217; 1 M 5-aza-dC treatment were analysed by Chromatin immunoprecipitation (ChIP) assay using antibodies that recognize Ac-H3K9 and di-methyl H3K9. The normal rabbit IgG was used as a negative control and Input indicates 5% input DNA, a positive amplification control.</p>
###xml 989 1981 988 1980 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="57">5-aza-dC treatment changes the chromatin conformation around the <italic>CIDE-A</italic> promoter. (<bold>A</bold>) Procedure of nuclease accessibility assay. Nuclei were digested with the restriction enzyme <italic>Alu</italic>I. DNA was extracted from the nuclei and amplified by PCR using a set of three primers (P1, P2 and P3). The decrease in the ratio 238:113 bp after <italic>Alu</italic>I digestion indicates that the chromatin is accessible to <italic>Alu</italic>I. (<bold>B</bold>) Chromatin accessibility changes in the critical <italic>CIDE-A</italic> promoter region in Hela, HEK-293T and BEL-7404 cells following treatment with 5-aza-dC. The ratio decreased significantly after treating with 1 M 5-aza-dC for 3 days. (<bold>C</bold>) <italic>In vivo</italic> H3K9 di-methylation and acetylation levels in the <italic>CIDE-A</italic> core promoter before and after 3 days&#8217; 1 M 5-aza-dC treatment were analysed by Chromatin immunoprecipitation (ChIP) assay using antibodies that recognize Ac-H3K9 and di-methyl H3K9. The normal rabbit IgG was used as a negative control and Input indicates 5% input DNA, a positive amplification control.</p></caption>
###xml 1981 1981 1980 1980 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1028f7"/>
###xml 980 1981 979 1980 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F7" position="float"><label>Figure 7.</label><caption><p textid="57">5-aza-dC treatment changes the chromatin conformation around the <italic>CIDE-A</italic> promoter. (<bold>A</bold>) Procedure of nuclease accessibility assay. Nuclei were digested with the restriction enzyme <italic>Alu</italic>I. DNA was extracted from the nuclei and amplified by PCR using a set of three primers (P1, P2 and P3). The decrease in the ratio 238:113 bp after <italic>Alu</italic>I digestion indicates that the chromatin is accessible to <italic>Alu</italic>I. (<bold>B</bold>) Chromatin accessibility changes in the critical <italic>CIDE-A</italic> promoter region in Hela, HEK-293T and BEL-7404 cells following treatment with 5-aza-dC. The ratio decreased significantly after treating with 1 M 5-aza-dC for 3 days. (<bold>C</bold>) <italic>In vivo</italic> H3K9 di-methylation and acetylation levels in the <italic>CIDE-A</italic> core promoter before and after 3 days&#8217; 1 M 5-aza-dC treatment were analysed by Chromatin immunoprecipitation (ChIP) assay using antibodies that recognize Ac-H3K9 and di-methyl H3K9. The normal rabbit IgG was used as a negative control and Input indicates 5% input DNA, a positive amplification control.</p></caption><graphic xlink:href="gkm1028f7"/></fig>
###xml 1872 1878 <span type="species:ncbi:9986">rabbit</span>
Chromatin conformation near the CIDE-A promoter was studied by the nuclease accessibility assay and ChIP assay. The nuclei from Hela, BEL-7404 and HEK-293T cells were digested with the restriction enzyme AluI. DNA extracted from the nuclei was amplified by PCR and analysed by electrophoresis. The ratio 238:113 bp represents the amount of undigested chromatin at the AluI site (-135/-130) in the CIDE-A promoter (Figure 7A). This ratio remained unchanged in these cells when compared with DNA from undigested nuclei, indicating that the AluI enzyme was not accessible to the AluI sequence in the chromatin and that the chromatin conformation was closed in these cells. After treatment with 1 muM 5-aza-dC, the ratio slightly decreased in BEL-7404 cells, while the decrease in the ratio was considerably more significant in Hela or HEK-293T cells (Figure 7B); this indicates that the chromatin around the CIDE-A promoter adopted a more open conformation after 5-aza-dC treatment. Figure 7.5-aza-dC treatment changes the chromatin conformation around the CIDE-A promoter. (A) Procedure of nuclease accessibility assay. Nuclei were digested with the restriction enzyme AluI. DNA was extracted from the nuclei and amplified by PCR using a set of three primers (P1, P2 and P3). The decrease in the ratio 238:113 bp after AluI digestion indicates that the chromatin is accessible to AluI. (B) Chromatin accessibility changes in the critical CIDE-A promoter region in Hela, HEK-293T and BEL-7404 cells following treatment with 5-aza-dC. The ratio decreased significantly after treating with 1 M 5-aza-dC for 3 days. (C) In vivo H3K9 di-methylation and acetylation levels in the CIDE-A core promoter before and after 3 days' 1 M 5-aza-dC treatment were analysed by Chromatin immunoprecipitation (ChIP) assay using antibodies that recognize Ac-H3K9 and di-methyl H3K9. The normal rabbit IgG was used as a negative control and Input indicates 5% input DNA, a positive amplification control.
###end p 56
###begin p 57
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 83 84 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 328 331 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 389 392 389 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Alu</italic>
###xml 396 397 396 397 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 622 623 622 623 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 625 632 625 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 683 689 683 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 883 889 <span type="species:ncbi:9986">rabbit</span>
5-aza-dC treatment changes the chromatin conformation around the CIDE-A promoter. (A) Procedure of nuclease accessibility assay. Nuclei were digested with the restriction enzyme AluI. DNA was extracted from the nuclei and amplified by PCR using a set of three primers (P1, P2 and P3). The decrease in the ratio 238:113 bp after AluI digestion indicates that the chromatin is accessible to AluI. (B) Chromatin accessibility changes in the critical CIDE-A promoter region in Hela, HEK-293T and BEL-7404 cells following treatment with 5-aza-dC. The ratio decreased significantly after treating with 1 M 5-aza-dC for 3 days. (C) In vivo H3K9 di-methylation and acetylation levels in the CIDE-A core promoter before and after 3 days' 1 M 5-aza-dC treatment were analysed by Chromatin immunoprecipitation (ChIP) assay using antibodies that recognize Ac-H3K9 and di-methyl H3K9. The normal rabbit IgG was used as a negative control and Input indicates 5% input DNA, a positive amplification control.
###end p 57
###begin p 58
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 563 569 563 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 586 594 586 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 1295 1301 1294 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
The epigenetic silencing of genes can result from the close connection between DNA methylation and histone code modifications in regions of transcriptional regulation. Dimethylated lysine 9 (di-methyl H3K9) and acetylated lysine 9 (Ac-H3K9) are two of the most widely studied histone modifications. Ac-H3K9 are typically associated with transcriptionally active promoters, whereas di-methyl H3K9 is associated with repressed promoters (19). We then utilized chromatin immunoprecipitation to determine the levels of the two histone H3 tail lysine modifications at CIDE-A gene promoters (Figure 7C). In Hela and BEL-7404 cells, where CIDE-A is none-expressed, high levels of di-methyl H3K9 were detected, whereas H3K9 acetylation was not detectable, consistent with their transcriptionally silent state. However, in HEK-293T cells, the H3K9 di-methylation levels of the promoter regions was similar with Hela and BEL-7404 cells, but having very low levels of detectable Ac-H3K9, which could explain the very low-level expression of CIDE-A. After treatment with 1 muM 5-aza-dC, H3K9 di-methylation was significantly diminished and H3K9 acetylation was obviously increased in all cases, which closely linked with gene reactivation. In light of our data above, we conclude that the activation of the CIDE-A locus was associated with chromatin remodeling after demethylation of the promoter region.
###end p 58
###begin title 59
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
CpG methylation inhibits the binding of Sp1 and Sp3 to the CIDE-A promoter in vivo
###end title 59
###begin p 60
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 355 361 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 399 405 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 418 426 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 491 497 490 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 550 557 549 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 559 568 558 567 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8.</label>
###xml 627 633 626 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 643 650 642 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 999 1005 998 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1061 1067 1060 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 568 1172 567 1171 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="61">CpG methylation inhibits the binding of Sp1 and Sp3 to the <italic>CIDE-A</italic> promoter <italic>in vivo</italic>. ChIP was performed using the chromatin from Hela cells with or without 3 days&#8217; 1 uM 5-aza-dC treatment. Protein&#8211;DNA complexes were subjected to immunoprecipitation using anti-Sp1 or anti-Sp3 antibodies. The normal rabbit IgG was used as a negative control. Protein-bound immunoprecipitated DNA was eluted and recovered for the PCR analysis of the <italic>CIDE-A</italic> promoter region by using a primer set specific for the <italic>CIDE-A</italic> promoter. Input represents the relative amounts of protein&#8211;DNA complex subjected to immunoprecipitation.</p>
###xml 568 1172 567 1171 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="61">CpG methylation inhibits the binding of Sp1 and Sp3 to the <italic>CIDE-A</italic> promoter <italic>in vivo</italic>. ChIP was performed using the chromatin from Hela cells with or without 3 days&#8217; 1 uM 5-aza-dC treatment. Protein&#8211;DNA complexes were subjected to immunoprecipitation using anti-Sp1 or anti-Sp3 antibodies. The normal rabbit IgG was used as a negative control. Protein-bound immunoprecipitated DNA was eluted and recovered for the PCR analysis of the <italic>CIDE-A</italic> promoter region by using a primer set specific for the <italic>CIDE-A</italic> promoter. Input represents the relative amounts of protein&#8211;DNA complex subjected to immunoprecipitation.</p></caption>
###xml 1172 1172 1171 1171 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1028f8"/>
###xml 559 1172 558 1171 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F8" position="float"><label>Figure 8.</label><caption><p textid="61">CpG methylation inhibits the binding of Sp1 and Sp3 to the <italic>CIDE-A</italic> promoter <italic>in vivo</italic>. ChIP was performed using the chromatin from Hela cells with or without 3 days&#8217; 1 uM 5-aza-dC treatment. Protein&#8211;DNA complexes were subjected to immunoprecipitation using anti-Sp1 or anti-Sp3 antibodies. The normal rabbit IgG was used as a negative control. Protein-bound immunoprecipitated DNA was eluted and recovered for the PCR analysis of the <italic>CIDE-A</italic> promoter region by using a primer set specific for the <italic>CIDE-A</italic> promoter. Input represents the relative amounts of protein&#8211;DNA complex subjected to immunoprecipitation.</p></caption><graphic xlink:href="gkm1028f8"/></fig>
###xml 866 872 <span type="species:ncbi:9986">rabbit</span>
To elucidate the effects of methylation of the CIDE-A promoter on the binding of Sp1 and Sp3 to the promoter, ChIP assays were performed in CIDE-A-non-expressing Hela cells. No detectable Sp1 and very weak Sp3 binding were observed in Hela cells, whereas treatment with 1 muM 5-aza-dC for 72 h markedly enhanced the binding affinity of Sp1 and Sp3 to the CIDE-A promoter along with the induction of CIDE-A expression (Figure 8). These findings suggested that methylation of CpG sites in the CIDE-A promoter interfered with the binding of Sp1 and Sp3 in vivo. Figure 8.CpG methylation inhibits the binding of Sp1 and Sp3 to the CIDE-A promoter in vivo. ChIP was performed using the chromatin from Hela cells with or without 3 days' 1 uM 5-aza-dC treatment. Protein-DNA complexes were subjected to immunoprecipitation using anti-Sp1 or anti-Sp3 antibodies. The normal rabbit IgG was used as a negative control. Protein-bound immunoprecipitated DNA was eluted and recovered for the PCR analysis of the CIDE-A promoter region by using a primer set specific for the CIDE-A promoter. Input represents the relative amounts of protein-DNA complex subjected to immunoprecipitation.
###end p 60
###begin p 61
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 431 437 431 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 493 499 493 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 298 304 <span type="species:ncbi:9986">rabbit</span>
CpG methylation inhibits the binding of Sp1 and Sp3 to the CIDE-A promoter in vivo. ChIP was performed using the chromatin from Hela cells with or without 3 days' 1 uM 5-aza-dC treatment. Protein-DNA complexes were subjected to immunoprecipitation using anti-Sp1 or anti-Sp3 antibodies. The normal rabbit IgG was used as a negative control. Protein-bound immunoprecipitated DNA was eluted and recovered for the PCR analysis of the CIDE-A promoter region by using a primer set specific for the CIDE-A promoter. Input represents the relative amounts of protein-DNA complex subjected to immunoprecipitation.
###end p 61
###begin title 62
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Knockdown of Sp1 and Sp3 expression by siRNA reduces CIDE-A promoter activity
###end title 62
###begin p 63
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 313 321 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Figure 9</xref>
###xml 498 504 498 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 814 822 814 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Figure 9</xref>
###xml 944 953 944 953 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 9.</label>
###xml 1006 1012 1006 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1033 1034 1033 1034 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1221 1222 1221 1222 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1258 1264 1258 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 953 1792 953 1790 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="64">Knockdown of Sp1 and Sp3 expression by siRNA reduces <italic>CIDE-A</italic> promoter activity. (<bold>A</bold>) Immunoblotting analysis of Sp1 and Sp3 protein levels in HEK-293T cells transfected with Sp1 and Sp3 siRNA. Control siRNA was used as negative control and Tublin as a loading control. (<bold>B</bold>) The effect of Sp1 or Sp3 siRNA on <italic>CIDE-A</italic> promoter activity detected by luciferase reporter assay. HEK-293T cells were transfected with Sp1 and Sp3 siRNAs individually or simultaneously and then transfected again with the luciferase reporter plasmid p(&#8722;137/&#8722;13) and p(&#8722;1556/&#8722;137). The activity of each promoter construct is shown as the luciferase activity relative to that of the pGL3-Basic vector. Values were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid and are shown as means &#177; SD for three independent experiments.</p>
###xml 953 1792 953 1790 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="64">Knockdown of Sp1 and Sp3 expression by siRNA reduces <italic>CIDE-A</italic> promoter activity. (<bold>A</bold>) Immunoblotting analysis of Sp1 and Sp3 protein levels in HEK-293T cells transfected with Sp1 and Sp3 siRNA. Control siRNA was used as negative control and Tublin as a loading control. (<bold>B</bold>) The effect of Sp1 or Sp3 siRNA on <italic>CIDE-A</italic> promoter activity detected by luciferase reporter assay. HEK-293T cells were transfected with Sp1 and Sp3 siRNAs individually or simultaneously and then transfected again with the luciferase reporter plasmid p(&#8722;137/&#8722;13) and p(&#8722;1556/&#8722;137). The activity of each promoter construct is shown as the luciferase activity relative to that of the pGL3-Basic vector. Values were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid and are shown as means &#177; SD for three independent experiments.</p></caption>
###xml 1792 1792 1790 1790 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkm1028f9"/>
###xml 944 1792 944 1790 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F9" position="float"><label>Figure 9.</label><caption><p textid="64">Knockdown of Sp1 and Sp3 expression by siRNA reduces <italic>CIDE-A</italic> promoter activity. (<bold>A</bold>) Immunoblotting analysis of Sp1 and Sp3 protein levels in HEK-293T cells transfected with Sp1 and Sp3 siRNA. Control siRNA was used as negative control and Tublin as a loading control. (<bold>B</bold>) The effect of Sp1 or Sp3 siRNA on <italic>CIDE-A</italic> promoter activity detected by luciferase reporter assay. HEK-293T cells were transfected with Sp1 and Sp3 siRNAs individually or simultaneously and then transfected again with the luciferase reporter plasmid p(&#8722;137/&#8722;13) and p(&#8722;1556/&#8722;137). The activity of each promoter construct is shown as the luciferase activity relative to that of the pGL3-Basic vector. Values were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid and are shown as means &#177; SD for three independent experiments.</p></caption><graphic xlink:href="gkm1028f9"/></fig>
To confirm the role of Sp1 and Sp3 in the regulation of CIDE-A promoter activity, we used RNA interference to knock down Sp1 and Sp3 expression in HEK-293T cells. Strongly reduced Sp1 and Sp3 protein levels were observed by Western blot analysis, whereas control siRNA had no effect on Sp1 or Sp3 protein levels (Figure 9A). HEK-293T cells were transfected with Sp1 and Sp3 siRNAs individually or simultaneously and then transfected again with the luciferase reporter plasmid containing the 125 bp CIDE-A core promoter. This resulted in a 38-58% reduction of luciferase activity in the presence of Sp1- or Sp3-specific siRNA compared to that with control siRNA. In contrast, no influence on transcriptional activity of control plasmid p(-1556/-137), which does not contain the Sp1/Sp3-binding motif, was observed (Figure 9B). These results indicate that Sp1 and Sp3 positively regulate the expression of CIDE-A by transactivating the promoter. Figure 9.Knockdown of Sp1 and Sp3 expression by siRNA reduces CIDE-A promoter activity. (A) Immunoblotting analysis of Sp1 and Sp3 protein levels in HEK-293T cells transfected with Sp1 and Sp3 siRNA. Control siRNA was used as negative control and Tublin as a loading control. (B) The effect of Sp1 or Sp3 siRNA on CIDE-A promoter activity detected by luciferase reporter assay. HEK-293T cells were transfected with Sp1 and Sp3 siRNAs individually or simultaneously and then transfected again with the luciferase reporter plasmid p(-137/-13) and p(-1556/-137). The activity of each promoter construct is shown as the luciferase activity relative to that of the pGL3-Basic vector. Values were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid and are shown as means +/- SD for three independent experiments.
###end p 63
###begin p 64
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 80 81 80 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 268 269 268 269 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 305 311 305 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Knockdown of Sp1 and Sp3 expression by siRNA reduces CIDE-A promoter activity. (A) Immunoblotting analysis of Sp1 and Sp3 protein levels in HEK-293T cells transfected with Sp1 and Sp3 siRNA. Control siRNA was used as negative control and Tublin as a loading control. (B) The effect of Sp1 or Sp3 siRNA on CIDE-A promoter activity detected by luciferase reporter assay. HEK-293T cells were transfected with Sp1 and Sp3 siRNAs individually or simultaneously and then transfected again with the luciferase reporter plasmid p(-137/-13) and p(-1556/-137). The activity of each promoter construct is shown as the luciferase activity relative to that of the pGL3-Basic vector. Values were normalized for transfection efficiency by cotransfection with the Renilla expression plasmid and are shown as means +/- SD for three independent experiments.
###end p 64
###begin title 65
DISCUSSION
###end title 65
###begin p 66
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Recent studies have shown that CIDE-A, which was originally identified as a proapoptotic protein, is strongly correlated with obesity. The expression pattern and functions of CIDE-A are well established; however, little is known about its transcriptional regulation. Since CIDE-A is considered as a novel target for therapeutic intervention of obesity and Type II diabetes, a better understanding of the mechanism responsible for the expression of this gene may provide new opportunities for therapy.
###end p 66
###begin p 67
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 216 222 216 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 356 362 356 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 542 548 542 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 750 756 750 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1077 1079 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1080 1082 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1189 1195 1189 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1325 1331 1325 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1393 1404 1393 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-B, NF1</italic>
###xml 1436 1439 1436 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APC</italic>
###xml 1488 1490 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1491 1493 1491 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1494 1496 1494 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1730 1736 1730 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
In the present study, we aimed to characterize the mechanism that regulated the tissue- and cell-specific expression of the CIDE-A gene. By using 5' flanking region-luciferase fusion plasmids, we identified the core CIDE-A promoter as a 125-bp region located between the base pairs -137 to -13 that contained two Sp1/Sp3-binding sites. The activity of the CIDE-A promoter was greatly reduced when site-directed mutations were introduced in each of these binding sites; this finding demonstrated a crucial role of the Sp1/Sp3-binding sites in CIDE-A promoter activity. In addition, EMSAs also confirmed that Sp1 and Sp3 could specifically bind to the putative binding sites identified in the minimal region. In view of this finding, the fact that the CIDE-A gene was expressed in a tissue- and cell-specific manner was rather confusing because Sp1 and Sp3 are two ubiquitously expressed mammalian transcription factors that bind to DNA with similar specificity and affinity and participate in the regulation of the expression of genes involved in almost all cellular processes (20,21). Thus, it appears that Sp1 and Sp3 alone might not determine tissue- and cell-specific expression of the CIDE-A gene. Interestingly, the basal promoter activity of the core region was observed even in cells that did not endogenously express CIDE-A. Similar phenomenon was also observed in previous studies on CIDE-B, NF1 (neurofibromatosis type 1) and APC (adenomatous polyposis of the colon) promoters (11,22,23). Since the transiently transfected constructs were unlikely to adopt the native chromatin structure, this observation prompted us to investigate whether DNA methylation was involved in the mechanisms underlying the silencing of the CIDE-A gene in non-expressing cells and tissues.
###end p 67
###begin p 68
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 467 473 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 600 608 600 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1160 1166 1160 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1282 1288 1282 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1726 1739 1726 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hMLH1, CDKN2B</italic>
###xml 1741 1749 1741 1749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p15INK4B</italic>
###xml 1755 1761 1755 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDKN2A</italic>
###xml 1763 1770 1763 1770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p16INK4</italic>
###xml 1773 1775 1773 1775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1956 1958 1956 1958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1959 1961 1959 1961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 2122 2128 2122 2128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2248 2254 2248 2254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
We investigated the DNA methylation profiles of a portion of the CpG island covering the Sp1/Sp3-binding sites. Sodium bisulfite sequencing analysis revealed that the CpG sites in the minimal promoter region were hypomethylated in CIDE-A expressed tissues (heart and adipose), but they were hypermethylated in CIDE-A absent or low expressed tissues (liver, spleen and stomach) and cell lines (Hela, BEL-7404 and HEK-293T cells). The involvement of methylation in the CIDE-A gene silencing was further supported by the finding that cells transfected by constructs densely methylated by SssI methylase in vitro showed a significant decrease in luciferase activities. Moreover, we found that after treatment with the methyltransferase inhibitor 5-aza-dC, the gene expression was restored in all the CIDE-A non-expressing cells. In addition, the nuclease accessibility assay demonstrated that the chromatin conformation around the Sp1/Sp3-binding sites in the CIDE-A non-expressing cells changed from 'closed' to 'open' after 5-aza-dC treatment. We further used ChIP to determine the levels of two critical histone H3 modifications (Ac-H3K9 and di-methyl H3K9) at CIDE-A gene core promoter. Consistent with the studies of other genes, we find that increased levels of di-methyl H3K9 at CIDE-A promoter correlates with a lack of gene expression, whereas an increased abundance of Ac-H3K9 correlates with increased gene expression. However, no significant changes were observed in CIDE-A expression levels, methylation status or chromatin conformation after the cells were treated with TSA, a histone deacetylase inhibitor. This observation is consistent with the previous reports on the regulation of hypermethylated genes such as hMLH1, CDKN2B (p15INK4B) and CDKN2A (p16INK4) (16). In these studies, 5-aza-dC treatment induced the expression of these hypermethylated genes and reversed histone modification, whereas TSA treatment did not induce these changes (16,24). Taken together, all these findings satisfy two well-known criteria for defining the role of DNA methylation in tissue- and cell-specific gene repression: (i) CIDE-A was densely methylated in non-expressing tissue and cells and (ii) induced demethylation resulted in the activation of CIDE-A.
###end p 68
###begin p 69
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 299 304 299 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26 B27 B28">26&#8211;28</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 717 722 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-Myb</italic>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 729 738 729 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-Myc/Myn</italic>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 745 748 745 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E2F</italic>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 755 759 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CREB</italic>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 806 809 806 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AP2</italic>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 841 850 841 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NF-&#954;B</italic>
###xml 867 872 863 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 876 878 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
The methylation of genomic DNA at CpG dinucleotides is a major epigenetic modification of the mammalian genome (25), and it functions in several aspects of gene expression such as X chromosome inactivation, genomic imprinting, immobilization of transposons and suppression of transcriptional noise (26-28). Methylation of CpG sites in the promoter region is also believed to ensure the silencing of tissue-specific genes (29). Several mechanisms have been proposed for methylation-induced gene repression. Among these mechanisms, the direct blocking of the binding of transcription factors to their CpG-containing binding sites is an important mechanism that contributes to transcriptional repression. In the case of c-Myb (30), c-Myc/Myn (31), E2F (32), CREB (cAMP-response element-binding protein) (33), AP2 (activator protein 2) (34) and NF-kappaB (nuclear factor kappaB) (35), methylated CpGs in their recognition site preclude the binding of the transcription factor and thereby directly inhibit gene expression.
###end p 69
###begin p 70
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CLDN4</italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 337 341 337 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 334 341 334 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>Cip1</sup></italic>
###xml 388 393 385 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GSTP1</italic>
###xml 407 408 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 428 435 425 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP-3</italic>
###xml 589 594 586 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38 B39 B40 B41">38&#8211;41</xref>
###xml 650 656 647 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 773 779 770 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 897 903 894 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1002 1006 999 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 999 1013 996 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21<sup>Cip1</sup>, GSTP1</italic>
###xml 1018 1025 1015 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGFBP-3</italic>
###xml 1199 1205 1195 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1270 1276 1266 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1408 1414 1404 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1517 1523 1513 1519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1614 1620 1610 1616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1651 1657 1647 1653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1814 1820 1810 1816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 1875 1881 1871 1877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2254 2260 2250 2256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2424 2426 2420 2422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 2436 2438 2432 2434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 2439 2441 2435 2437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 2453 2455 2449 2451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 2456 2458 2452 2454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 2475 2481 2471 2477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 2670 2676 2666 2672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
Previous studies have shown that the Sp1-binding affinity to its responding element is not consequentially affected by DNA methylation, which appears to be promoter dependent. The Sp1-binding affinity to the luteinizing hormone receptor (LHR) or CLDN4 promoter was not affected by DNA methylation (36,37). In contrast, in the case of p21Cip1, 11 beta-hydroxysteroid dehydrogenase type 2, GSTP1 (glutathione S-transferase p1) or IGFBP-3 (insulin-like growth factor-binding protein-3), the Sp1-binding affinity to the respective promoter region was found to be abolished by DNA methylation (38-41). Because of the vital roles of Sp1/Sp3 in maintaining CIDE-A basal promoter activity, we further investigated whether DNA methylation could impair the binding of Sp1/Sp3 to the CIDE-A promoter in non-expressing cells. In our study, the ChIP assay clearly showed that the binding of Sp1 and Sp3 to the CIDE-A promoter could be diminished by methylation of the Sp1/Sp3 motif, similar to that observed for p21Cip1, GSTP1 and IGFBP-3 promoters; furthermore, treatment of Hela cells with 1 muM 5-aza-dC for 3 days markedly enhanced the binding affinity of Sp1/Sp3 along with restoration of the expression of CIDE-A. We further confirmed the roles of Sp1 and Sp3 in regulation of CIDE-A promoter activity by using RNA interference. Consistent with our reporter assays demonstrating a crucial role for Sp1/Sp3 sites in CIDE-A promoter activity, Sp1 and Sp3 knockdown significantly reduced transcription levels controlled by the CIDE-A promoter. Taken together, our results clearly indicate that the methylation status of the CIDE-A promoter correlated well with CIDE-A gene expression in a subset of cell lines and tissues, and that DNA methylation was the key mechanism of regulating tissue- and cell-specific expression of CIDE-A through blocking of the binding of Sp1 and Sp3 to the CIDE-A promoter. Our findings also suggest that the switch between transcriptional silencing and expression of the tissue-specific gene could depend on varying epigenetic modification, which is driven by basal transcription factors such as Sp1/Sp3 and activation of the conserved promoter sites. It would be interesting to investigate the change in the methylation status of the CIDE-A promoter during adipose differentiation and to determine whether the regulation of higher-order chromatin structures by methyl-CpG-binding proteins such as MeCP1 (42), MeCP2 (43,44) and MBD2 (43,45) is involved in CIDE-A gene silencing in non-expressing cells and tissues. Such information would provide further insights into the role of CpG methylation in the regulation of tissue-specific expression of the CIDE-A gene.
###end p 70
###begin p 71
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 151 157 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
###xml 477 483 477 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIDE-A</italic>
In conclusion, our data revealed that DNA methylation of CpG sites in the CIDE-A promoter was the primary mechanism through which the transcription of CIDE-A was silenced or repressed in non-expressing cells and tissues. In addition, we showed that the Sp1/Sp3 consensus sequence-the critical regulatory elements-were methylated, and methylation of this motif prohibited the access of Sp1 and Sp3 transcriptional factors, resulting in the downregulation of the activity of the CIDE-A promoter.
###end p 71
###begin title 72
ACKNOWLEDGEMENTS
###end title 72
###begin p 73
We are grateful to other members of our group for technical assistance and helpful discussion. This work was supported by grants from the National High Technology Research and Development of China (863 Program; No.2006AA02Z190 and No.2002BA711A02), the National Natural Sciences Foundation of China (No.30571059). Funding to pay the Open Access publication charges for this article was provided by 863 Program (No.2006AA02Z190).
###end p 73
###begin p 74
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 74
###begin title 75
REFERENCES
###end title 75
###begin article-title 76
Cell death: the significance of apoptosis
###end article-title 76
###begin article-title 77
Cloning and transcriptional regulation of a novel adipocyte-specific gene, FSP27. CAAT-enhancer-binding protein (C/EBP) and C/EBP-like proteins interact with sequences required for differentiation-dependent expression
###end article-title 77
###begin article-title 78
CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor
###end article-title 78
###begin article-title 79
Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family
###end article-title 79
###begin article-title 80
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Cidea-deficient mice have lean phenotype and are resistant to obesity
###end article-title 80
###begin article-title 81
###xml 80 85 <span type="species:ncbi:9606">women</span>
Changes in adipose tissue gene expression with energy-restricted diets in obese women
###end article-title 81
###begin article-title 82
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity
###end article-title 82
###begin article-title 83
CIDE-A, a novel link between brown adipose tissue and obesity
###end article-title 83
###begin article-title 84
The CIDEA gene V115F polymorphism is associated with obesity in Swedish subjects
###end article-title 84
###begin article-title 85
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
Transcriptional regulation of Cidea, mitochondrial cell death-inducing DNA fragmentation factor alpha-like effector A, in mouse liver by peroxisome proliferator-activated receptor alpha and gamma
###end article-title 85
###begin article-title 86
###xml 59 64 <span type="species:ncbi:9606">human</span>
Dual promoters control the cell-specific expression of the human cell death-inducing DFF45-like effector B gene
###end article-title 86
###begin article-title 87
###xml 15 23 <span type="species:ncbi:274808">searcher</span>
The CpG island searcher: a new WWW resource
###end article-title 87
###begin article-title 88
###xml 18 23 <span type="species:ncbi:9606">human</span>
Regulation of the human MSH6 gene by the Sp1 transcription factor and alteration of promoter activity and expression by polymorphisms
###end article-title 88
###begin article-title 89
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands
###end article-title 89
###begin article-title 90
Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines
###end article-title 90
###begin article-title 91
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
###end article-title 91
###begin article-title 92
Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression
###end article-title 92
###begin article-title 93
Two polymorphic variants of wild-type p53 differ biochemically and biologically
###end article-title 93
###begin article-title 94
An epigenetic road map for histone lysine methylation
###end article-title 94
###begin article-title 95
###xml 61 66 <span type="species:ncbi:9606">human</span>
Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs
###end article-title 95
###begin article-title 96
A tale of three fingers: the family of mammalian Sp/XKLF transcription factors
###end article-title 96
###begin article-title 97
Characterization of functional elements in the neurofibromatosis (NF1) proximal promoter region
###end article-title 97
###begin article-title 98
Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with the binding of transcription factor CCAAT-binding factor
###end article-title 98
###begin article-title 99
Dependence of histone modifications and gene expression on DNA hypermethylation in cancer
###end article-title 99
###begin article-title 100
Methylation of CpG sequences in eukaryotic DNA
###end article-title 100
###begin article-title 101
Methylation-induced repression-belts, braces, and chromatin
###end article-title 101
###begin article-title 102
The role of DNA methylation in mammalian epigenetics
###end article-title 102
###begin article-title 103
Epigenetic reprogramming in mammalian development
###end article-title 103
###begin article-title 104
Role of DNA methylation in the regulation of transcription
###end article-title 104
###begin article-title 105
Methylation-sensitive DNA binding by v-myb and c-myb proteins
###end article-title 105
###begin article-title 106
###xml 24 30 <span type="species:ncbi:10090">murine</span>
Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation
###end article-title 106
###begin article-title 107
CpG methylation as a mechanism for the regulation of E2F activity
###end article-title 107
###begin article-title 108
Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo
###end article-title 108
###begin article-title 109
CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2
###end article-title 109
###begin article-title 110
A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus
###end article-title 110
###begin article-title 111
Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription
###end article-title 111
###begin article-title 112
Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells
###end article-title 112
###begin article-title 113
Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter
###end article-title 113
###begin article-title 114
Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression
###end article-title 114
###begin article-title 115
Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells
###end article-title 115
###begin article-title 116
Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer
###end article-title 116
###begin article-title 117
DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein
###end article-title 117
###begin article-title 118
Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA
###end article-title 118
###begin article-title 119
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin
###end article-title 119
###begin article-title 120
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
###end article-title 120

